.*Data users need to apply an application for Using NBDC Human Data to reach the Controlled-access Data. Learn more
| Research ID | Study Title | Release Date | Type of Study | Platform |
Participants/Materials (Ethnicity) | Data Provider | Type of Data |
|---|---|---|---|---|---|---|---|
|
JGAS000002 |
Sequence Data of a SCA31 Patient |
v1:2013/12/01 |
Single Patient NGS (WGS) |
Illumina (HiSeq 2000) |
1 Patient (Japanese) |
Shinichi Morishita |
Controlled-access (Type I) |
|
JGAS000001 |
Molecular Epidemiological Study of Somatic Mutation Profiles of EGFR Mutation Positive Lung Adenocarcinoma |
v1:2014/07/11 |
NGS (Exome) |
Illumina (Genome Analyzer IIx) |
97 Patients (Japanese) |
Koichi Goto |
Controlled-access (Type I) |
|
DRA001273 JGAS000032 DRA003791 JGAS000093 JGAS000123 JGAS000166 JGAS000191 JGAS000192 JGAS000200 JGAS000201 JGAS000323 JGAS000490 |
Genetic Analysis of Hearing Loss and Its Clinical Application |
v1:2014/01/27 v2:2017/02/24 v3:2017/06/19 v4:2018/02/13 v5:2019/04/18 v6:2021/07/30 v7:2021/11/19 v8:2023/10/02 |
NGS (Target Capture) |
Thermo Fisher Scientific (Ion PGM, Ion Proton, Ion S5) Illumina (HiSeq 2000) |
17 UsherSyndrome patients 3,156 Non-syndromic hearing loss patients (Japanese) |
Shin-ichi Usami |
Unrestricted-access Controlled-access (Type I) |
|
JGAS000004 JGAS000106 JGAS000146 JGAS000325 |
Genomic and Genetic Analysis of Brain Tumors and Analysis of Their Clinicopathological Significance |
v1:2014/01/31 v2:2017/06/05 v3:2017/09/01 v4:2019/02/13 v5:2022/08/08 |
NGS (Exome, RNA-seq, Target Capture) Methylation array |
Illumina (HiSeq 2000/2500, HumanMethylation450) |
6 astrocytomas 16 oligodendrogliomas gliomas (17 cerebellar gliomas, 8 cerebral glioblastomas and 14 thalamic gliomas) 94 gliomas 12 cerebral cavernous malformations 1 vertebral hemangioma 3 orbital cavernous malformations (Japanese) |
Nobuhito Saito (P-DIRECT) |
Controlled-access (Type I) |
|
JGAS000005 |
Gene Expression of Human Th17 Cells Before and After Activation |
v1:2015/02/12 |
NGS (RNA-seq) |
Applied BioSystems (5500 Genetic Analyzer) |
1 Participant (4 Samples) (Japanese) |
Sanju Iwamoto |
Controlled-access (Type I) |
|
JGAS000007 |
Research for genetic causes and mechanisms of Hirschsprung's
|
v1:2018/01/29 |
NGS (Exome) |
Illumina (HiSeq 2000) |
5 Patients with Hirschsprung's diseases and 6 their families (Japanese) |
Hiroshi Matsufuji |
Controlled-access (Type I) |
|
DRA003802 |
DNA Methylation Analysis of Early Human Embryos |
v1:2014/12/24 v2:2015/01/07 v3:2015/08/03 |
NGS (PBAT-seq) |
Illumina (HiSeq 2000/2500) |
11 Libraries (Japanese) |
Takahiro Arima |
Unrestricted-access |
|
JGAS000008 |
Research for candidate genes of splenic epidermoid cyst. |
v1:2015/06/23 |
NGS (Exome) |
Illumina (HiSeq 2000) |
8 Splenic epidermoid cysts (Japanese) |
Hiroshi Matsufuji |
Controlled-access (Type I) |
|
JGAS000015 |
Integrated hepatitis B virus is epigenomically regulated by the methylation status of the human genome |
v1:2015/10/07 |
NGS (Target Capture) |
Roche GS FLX Titanium |
2 Cell lines 8 HB-HCC primary tissues (Japanese) |
Hiroyuki Yamamoto |
Controlled-access (Type I) |
|
JGAS000012 |
Nagahama Zero-ji Preventive Cohort Project |
v1:2015/08/19 |
SNP-chip Control Set Cohort |
Illumina (Human610-Quad, HumanOmni2.5-4/2.5-8/2.5S-8, HumanExome-12, HumanCoreExome-12) |
3712 Participants (Japanese) |
Fumihiko Matsuda |
Controlled-access (Type I) |
|
Japan PGx Data Science Consortium Database |
v1:2014/10/16 |
SNP-chip Control Set |
Illumina (HumanOmni2.5-8) |
2994 Participants (Japanese) |
Koji Suematsu |
Unrestricted-access |
|
|
JGAS000101 JGAS000114* JGAS000140 JGAS000203 JGAS000293 JGAS000327 JGAS000346 JGAS000381* JGAS000414 JGAS000347 JGAS000592 JGAS000647 JGAS000698 JGAS000699 JGAS000700 JGAS000701 JGAS000703 JGAS000738 |
Bio Bank Japan project |
v1:2014/09/30 v2:2015/12/28 v3:2016/01/28 v4:2016/02/02 v5:2017/05/18 v6:2017/09/08 v7:2018/04/04 v8:2018/05/01 v9:2018/08/07 v10:2018/08/13 v11:2018/10/16 v12:2018/12/10 v13:2019/01/25 v14:2019/03/26 v15:2019/09/27 v16:2019/10/07 v17:2019/10/08 v18:2019/11/26 v19:2020/04/20 v20:2020/08/17 v21:2020/08/25 v22:2021/05/21 v23:2021/07/13 v24:2021/11/26 v25:2022/01/25 v26:2022/04/01 v27:2023/01/18 v28:2023/04/05 v29:2023/04/05 v30:2023/04/20 v31:2023/09/01 v32:2024/01/11 v33:2024/05/27 v34:2024/09/19 v35:2024/10/25 |
SNP-chip Case-Control NGS (WGS, Target Capture) |
Illumina (Human610-Quad, HumanHap550v3, HumanOmniExpress-12, HumanExome, OmniExpressExome, HumanExome-12, Infinium OmniExpress-24, Infinium HumanOmniExpressExome-8, HiSeq 2500/X Five) Perlegen Sciences (high-density oligonucleotide arrays) Hologic Japan (Invader) |
v1:1666 MIs and 3198 ctrls v2:934 ctrls (JSNP) v2:35 diseases (JSNP) v2:182 esophageal cancers (JSNP) v2:92 ALSs (JSNP) v3:9817 T2DMs and 6763 ctrls v3:5646 T2DMs and 19,420 ctrls v4:1472 ADs and 7966 ctrls v5:8180 AFs and 28,612 ctrls v6:158,284 individuals for BMI study v6:182,505 individuals' genotype data v7:3980 POAGs and 18,815 ctrls v8:162,255 individuals for 58 quantitative traits study v9:67,029 females with information on age at menarche v9:43,861 females with information on age at menopause v10:1,026 individuals for WGS v11:7,104 breast cancer patients and 23,731 controls v12:2,809 T2DM with diabetic nephropathy patients and 5,592 T2DM ctrls v13:36,614 T2DMs and 155,150 ctrls v14:165,436 individuals with information on smoking behaviour v15:1,026 individuals from biobank Japan and 2,504 individuals from 1KGP p3v5 ALL v15:159,095 individuals for height study v16:7,636 prostate cancer patients and 12,366 ctrls v17,18,21:212,453 individuals for 42 diseases v19:165,084 individuals with information on dietary habits v2025,892 CADs and 142,336 ctrls v22:11,234 individuals from biobank Japan v23:768 individuals from biobank Japan v24:1,005 pancreatic cancer patients, 12,503 colorectal cancer patients and 23,705 ctrls v25:1,765 myocardial infarction patients and 199 dementia patients v26:740 renal cell cancer patients and 5,996 controls v27:137,693 individuals from biobank Japan v28:4,880 individuals from biobank Japan v29:9,826 AFs and 140,446 ctrls (BBJ cohot) 60,620 AFs and 970,216 ctrls (European) 7,244 AFs and 56,378 ctrls (FinnGenn) v30:1,982 lymphoma patients, 10,366 gastric cancer patients and 37,592 controls (BBJ cohot) v32:1,007 individuals from biobank Japan v33: 256 gastric cancer patients v33: 269,000 patients for 51 diseases v33: 617 colorectal cancer patients v33: 2,162 diabetes patients v33: 2,067 gastric cancer patients v35: 7,472 individuals from BBJ 1st cohort (Japanese, European, Finnish) |
Michiaki Kubo |
Unrestricted-access Controlled-access (Type I) |
|
JGAS000159 |
Construction of the Whole-genome Reference Panel of 3552 Japanese Individuals |
v1:2014/10/14 v2:2018/12/27 v3:2019/01/11 |
NGS (WGS) |
Illumina (HiSeq 2500) |
3552 Participants (Japanese) |
Masayuki Yamamoto (ToMMo) |
Unrestricted-access |
|
DRA002604 |
Epigenome analysis of proteins expressed in human testis |
v1:2016/09/30 |
NGS (ChIP-seq, RNA-seq) |
Illumina (HiSeq 1500) |
1 Participant (4 Samples) (Japanese) |
Yasuyuki Ohkawa |
Unrestricted-access |
|
JGAS000021 |
Exome sequencing of primary central nervous system lymphoma |
v1:2016/02/22 |
NGS (Exome, RNA-seq) |
Illumina (HiSeq 2000) |
41 PCNSLs (Japanese) |
Hiroyuki Mano |
Controlled-access (Type I) |
|
JGAS000009 |
Genetic analysis in neurodegenerative disorders |
v1:2015/02/03 |
NGS (Exome) |
Illumina (HiSeq 2000) |
14 MSAs and 7 Controls (Japanese) |
Shoji Tsuji |
Controlled-access (Type I) |
|
JGAS000011 |
Systematic identification of long non-coding RNAs potentially involved in gastrointestinal cancer |
v1:2015/04/01 |
NGS (RNA-seq) Tumor vs. Matched-Normal |
Illumina (HiSeq 2500) |
17 GICs (32 Samples) (Japanese) |
Yasuhisa Shinomura (Genome Science) |
Controlled-access (Type I) |
|
JGAS000013 |
Genetic Analysis in Amyotrophic Lateral Sclerosis |
v1:2015/01/08 |
NGS (Exome) |
Illumina (HiSeq 2000) |
11 ALSs (Japanese) |
Fumiaki Tanaka (Genome Science) |
Controlled-access (Type I) |
|
JGAS000014 JGAS000273 |
Genetic Analysis in Psychiatric Disorders |
v1:2015/01/08 v2:2021/03/05 v3:2021/04/20 |
NGS (Exome) |
Illumina (HiSeq 2000/2500) |
Healthy Monozygotic Twins: 3 Pairs (6 Participants) 66 + 78 trios with bipolar disorder proband and unaffected parents (Japanese) |
Tadafumi Kato (Genome Science) |
Controlled-access (Type I) |
|
JGAS000017 |
Analysis of the Molecular Mechanism for Developing Donor-Origin Leukemia after Allogeneic Stem Cell Transplantation. |
v1:2015/02/02 |
NGS (Exome) |
Illumina (HiSeq 2000) |
1 DCL (5 Samples from Each Stage) 1 Donor (Japanese) |
Hitoshi Kiyoi (P-DIRECT) |
Controlled-access (Type I) |
|
JGAS000016 |
Genetic Analysis in Lifestyle-Related Disease, Arteriosclerotic Disease, and Aging-Related Diseases |
v1:2015/01/28 |
NGS (Exome) |
Illumina (HiSeq 2000) |
30 Hypertensions (Japanese) |
Tetsurou Miki (Genome Science) |
Controlled-access (Type I) |
|
JGAS000023 |
Comprehensive Analysis of Genetic Alterations in Hematological Malignancies |
v1:2015/04/16 |
NGS (Exome) |
Illumina (Genome Analyzer IIx, HiSeq 2000/2500) |
13 MDSs and 1 CMML (Japanese) |
Seishi Ogawa (P-DIRECT) |
Controlled-access (Type I) |
|
JGAS000024 JGAS000040 |
Identification of genetic polymorphism on aggressive periodontitis |
v1:2016/07/28 |
NGS (Exome) |
Illumina (HiSeq 2000) |
Periodontitis patients (Japanese) |
Shinya Murakami |
Controlled-access (Type I) |
|
JGAS000018 |
Biobank Japan Project |
v1:2015/06/02 v2:2018/06/05 |
SNP-chip |
Illumina (HumanOmniExpress, HumanExome, ImmunoChip, HumanHap550v3 Genotyping BeadChip) |
908 Participants (Japanese) |
Michiaki Kubo (BBJ) |
Controlled-access (Type I) |
|
Study of Genome Polymorphism/Variation on Stevens-Johnson Syndrome |
v1:2016/03/09 v1:2020/12/21 |
SNP-chip Case-Control |
Affymetrix (Axiom ASI) Illumina (HiSeq X Ten) |
117 SJSs and 691 controls 133 SJS/TENs and 418 controls (Japanese) |
Mayumi Ueta (Genome Science) |
Unrestricted-access |
|
|
JGAS000022 JGAS000560 |
The Molecular Biological Analysis about Occurrence and Malignant Transformation in gynecological carcinogenesis |
v1:2015/04/01 v2:2024/05/10 v3:2024/07/05 |
SNP-chip CNV Analysis NGS (Exome, RNA-seq) Methylation array Expression array |
Affymetrix (Human Mapping 250K Nsp Array, GeneChip® Human Genome U133 Plus 2.0 Array) Illumina (HiSeq 2000, Infinium HumanMethylation450) |
57 + 111 + 31 Ovarian carcinomas (Japanese) |
Katsutoshi Oda (P-DIRECT) |
Controlled-access (Type I) |
|
JGAS000042 |
Constructing database of magnetic resonance imaging of the brain and the ancillary clinical information for multisite collaboration studies |
v1:2015/11/20 |
Neuroimage Clinical Info |
Philips (Achieva) |
129 normal controls, 37 schizophrenia, 8 unipolar and 2 bipolar disorders (Japanese) |
Kiyoto Kasai |
Unrestricted-access Controlled-access (Type I) |
|
JGAS000026 JGAS000027 JGAS000028 |
Standard epigenome mapping in human epithelial cells of the digestive and urogenital organs (HPC series) |
v1:2016/07/22 |
NGS (PBAT-seq, ChIP-seq, RNA-seq) |
Illumina (HiSeq 2000/2500) |
8 partial hepatectomy specimens (Japanese) |
Yae Kanai (IHEC) |
Controlled-access (Type I) |
|
DRA003516 |
Functional analysis of two types of exosome in human whole saliva |
v1:2015/05/01 |
NGS (RNA-seq) |
Illumina (Genome Analyzer IIx) |
1 Participant (3 Samples) (Japanese) |
Ryohei Yanoshita |
Unrestricted-access |
|
JGAS000037 |
Identification of novel therapeutic targets of small cell lung cancer by comprehensive genomic analyses |
v1:2015/10/01 |
NGS (Exome) |
Illumina (HiSeq 2000) |
51 SCLCs (Japanese) |
Koichi Goto (P-DIRECT) |
Controlled-access (Type I) |
|
JGAS000036 JGAS000046 JGAS000088 JGAS000188 JGAS000204 JGAS000246 |
Genome wide analysis of gene mutations in solid tumors |
v1:2015/09/16 v2:2017/12/26 v3:2020/05/29 v4:2020/12/14 v5:2020/12/18 |
NGS (Exome, Target Capture, RNA-seq) SNP-chip Methylation array |
Illumina (HiSeq 2000/2500, MiSeq, MethylationEPIC) Affymetrix (Human Mapping 250K Nsp, CytoScan HD) |
16 RMSs 7 PPBs 522 NBs 39 neuroblastoma cell lines 10 PBLs 59 HBLs 2 HBL cell lines 51 patients with pediatric germ cell tumors 30 patients with high-risk neuroblastoma (Japanese) |
Junko Takita (P-DIRECT) |
Controlled-access (Type I) |
|
DRA003736 |
Performance Comparison of Four Commercial Human Whole-Exome Capture Platforms |
v1:2015/08/01 |
NGS (Exome) Platform comparison |
Illumina (HiSeq 2500) |
2 HapMap-JPT samples (Japanese) |
Michiaki Kubo |
Unrestricted-access |
|
JGAS000035 |
Diagnostic feasibility study for pathological prediction with rheumatoid arthritis-susceptible genes and genomic regions identified by the association analysis using microsatelite markers |
v1:2015/09/24 |
NGS (Exome) |
Illumina (HiSeq 2000) |
39 RAs 10 Controls (pooled) (Japanese) |
Shigeki Mitsunagai (Genome Science) |
Controlled-access (Type I) |
|
JGAS000041 |
Genetic analysis in an inherited cardiac arrhythmia |
v1:2015/11/18 |
NGS (Exome) |
Illumina (HiSeq 2000) |
11 Patients with an inherited cardiac arrhythmia (Japanese) |
Naomasa Makita (Genome Science) |
Controlled-access (Type I) |
|
JGAS000039 |
Analysis of TKI resistant mechanism for gastrointstinal stromal tumor (GIST) |
v1:2016/12/27 |
NGS (Exome) |
Illumina (HiSeq 1500) |
4 Imatinib resistant GIST (Japanese) |
Tsuyoshi Takahashi |
Controlled-access (Type I) |
|
JGAS000038 |
Epigenomic analysis of the human placenta |
v1:2016/09/16 |
NGS (WGS, Exome, RNA-seq, BS-seq) |
Illumina (HiSeq 2500) |
28 human placenta 26 maternal blood samples (Japanese) |
Takahiro Arima (IHEC) |
Controlled-access (Type I) |
|
JGAS000052 |
Research of factors related to diagnosis, progression, prognosis and treatment of hepato-biliary-pancreatic malignancies |
v1:2017/01/12 |
NGS (Exome, Target Capture) |
Illumina (HiSeq 2000) |
33 primary HCC (Japanese) |
Shinji Tanaka (P-DIRECT) |
Controlled-access (Type I) |
|
Genome analysis for elucidation of genetic factors in orofacial traits and diseases |
v1:2016/03/02 |
NGS (WGS) |
Illumina (HumanOmniExpress) |
146 TMJ and 374 controls 149 third molar agenesis and 338 controls (Japanese, Korean) |
Tetsutarou Yamaguchi (Genome Science) |
Controlled-access (Type I) |
|
|
JGAS000051 |
Japanese Alzheimer's disease neuroimaging initiative (J-ADNI) |
v1:2016/01/29 |
Neuroimage Clinical Info |
234 MCI 154 AD 149 healthly controls (Japanese) |
Takeshi Iwatsubo |
Unrestricted-access Controlled-access (Type I) |
|
|
DRA004162 |
Research about retrovirus infection |
v1:2016/10/31 |
NGS (ChIP-seq) |
Illumina (NextSeq 500) |
1 ED (ATL cell line) (Cell-line) |
Yorifumi Satou |
Unrestricted-access |
|
JGAS000047 |
Transcriptome analysis of acute lymphoblastic leukemia in adolescents and young adults |
v1:2016/03/29 |
NGS (RNA-seq) |
Illumina (HiSeq 2000/2500) |
99 Ph(-) ALL 3 Ph(+) ALL 5 cell lines 8 normal hematopoietic cells (Japanese) |
Hiroyuki Mano (P-DIRECT) |
Controlled-access (Type I) |
|
DRA004251 |
Whole exome sequencing on ampullary carcinomas |
v1:2016/02/05 |
NGS (Exome) |
Illumina (HiSeq 2000/2500) |
60 Patients with ampullary cancer (28 Japanese patients and 32 American patients) |
Shinich Yachida |
Unrestricted-access |
|
JGAS000053 |
Transcriptome analysis of Hepatitis B for drug discovery and clinical applications |
v1:2016/09/30 |
NGS (CAGE-seq) |
Illumina (HiSeq 2000) |
8 HBV (Genotype C) positive patients (Japanese) |
Tomokazu Matsuura |
Controlled-access (Type I) |
|
JGAS000062 JGAS000176 |
Identification of new molecular targets with profiling of malignant mesothelioma |
v1:2016/07/20 v2:2020/04/14 |
NGS (Exome, WGS) |
Illumina (HiSeq 2000/2500) 10x Genomics (Chromium Controller) |
38 Malignant pleural mesothelioma (Japanese) |
Takashi Nakano (P-DIRECT) |
Controlled-access (Type I) |
|
JGAS000059 |
Genetic and epigentic analysis of non-alcoholic fatty liver disease |
v1:2017/02/20 |
NGS (RNA-seq) Methylation array |
Illumina (HiSeq 2500, HumanMethylation450) |
64 NAFLD patients (Japanese) |
Kikuko Hotta (Genome Science) |
Controlled-access (Type I) |
|
Genome and Multi-layer omics reference panels using blood samples from a population-based cohort study |
v1:2018/03/30 |
NGS (WGS, WGBS, RNA-seq) |
Illumina (HiSeq 2500/X) |
197 participants (Japanese) |
Atsushi Shimizu |
Unrestricted-access |
|
|
JGAS000091 |
Identification of genetic mutations characteristic for recurrence and metastasis of colorectal cancer. |
v1:2018/04/06 |
NGS (Exome) |
Illumina (HiSeq 2000) |
89 colorectal cancers (Japanese) |
Toshiharu Yamaguchi (P-DIRECT) |
Controlled-access (Type I) |
|
JGAS000104 |
Identification of genetic mutations characteristic for recurrence of serous ovarian cancer |
v1:2018/04/06 |
NGS (Exome) |
Illumina (HiSeq 2000) |
65 ovarian cancer (Japanese) |
Kazuyoshi Kato (P-DIRECT) |
Controlled-access (Type I) |
|
JGAS000075 |
Identification of genetic mutations characteristic for recurrence and metastasis of breast cancer |
v1:2018/04/03 |
NGS (Exome) |
Illumina (HiSeq 2000) |
65 recurrent / metastatic breast cancer patients (Japanese) |
Yoshio Miki (P-DIRECT) |
Controlled-access (Type I) |
|
JGAS000057 |
Searching causative genes of familial tumors using whole genome / exome sequencing |
v1:2017/02/20 |
NGS (Exome) |
Illumina (HiSeq 2000) |
Siblings developed multiple primary lung cancers (Japanese) |
Kikuya Kato |
Controlled-access (Type I) |
|
JGAS000061 |
Construction of Geriatric Oncology Database for establishment of the Treatment Algorithm: Clinical Data and Questionnaire Survey Results in JapaneseElderly Cancer Patients Retrospective study |
v1:2016/08/26 |
Direct sequencing TaqMan qRT-PCR COBRA cDNA microarray Clinical data Treatment data |
Applied BioSystems (3130 Genetic Analyzer) Roche (LightCycler 480II) Agilent Technologies (Whole Human Genome Microarray 4x44K) |
[GENOME] 106 colorectal cancer 62 gastric cancer 173 lung cancer [Retrospective] 313 colorectal cancer 166 gastric cancer 344 lung cancer 300 diabetes and nephropathy 357 cardiovascular disorder 49 respiratory dysfunction (Japanese) |
Masahiko Nishiyama |
Controlled-access (Type I) |
|
JGAS000089 |
Shuttle system between petient-derived xenograft and ex vivo culture for innovative platform of evaluating drug sensitivity |
v1:2018/04/06 |
NGS (Exome) |
Illumina (HiSeq 2000) |
8 colorectal cancer 2 lung cancer 2 small cell carcinoma of uterine cervix (Japanese) |
Masahiro Inoue (P-DIRECT) |
Controlled-access (Type I) |
|
JGAS000060 |
Investigating the mechanisms of tumor recurrence and metastasis by non-coding RNA |
v1:2016/08/01 |
NGS (Exome) |
Illumina (HiSeq 2000) |
9 colorectal carcinomas (Japanese) |
Koshi Mimori |
Controlled-access (Type I) |
|
JGAS000076 |
Project for Development of Innovative Research on Cancer Therapeutics; identifiying the predictive factors for response to chemoherapy in ovarian cancer |
v1:2017/05/18 |
NGS (Exome) |
Illumina (HiSeq 2000) |
55 ovarian clear cell carcinoma patients (Japanese) |
Toru Sugiyama (P-DIRECT) |
Controlled-access (Type I) |
|
JGAS000065* JGAS000349 JGAS000570 JGAS000677 |
Cancer genomics for elucidation of molecular mechanisms of carcinogenecis and progression in lung cancer |
v1:2017/07/10 v2:2020/10/19 v3:2021/12/14 v4:2022/03/23 v5:2022/12/27 v6:2023/02/10 v7:2023/06/19 v8:2023/09/22 v9:2024/04/10 |
NGS (PCR amplicon Seq, WGS, RNA-seq, scDNA-seq, Target Capture, Visium Spatial Gene Expression) Histological image Multiplex Fluorescence Immunostaining Xenium In Situ Gene Expression |
Nanopore (MinION, PromethION) Illumina (NovaSeq 6000, HiSeq 2000) Akoya Biosciences (PhenoCycler) 10x Genomics (Xenium Analyzer) |
8 + 21 + 74 + 20 lung adenocarcinoma patients (Japanese) |
Takashi Kono |
Controlled-access (Type I) |
|
JGAS000064 |
RNA expression profiling of neuromuscular diseases and viral diseases |
v1:2016/12/09 |
NGS (small RNA-seq) |
Illumina (HiSeq 2500) |
3 Neuromuscular disease (control group) (Japanese) |
Takanori Yokota |
Controlled-access (Type I) |
|
JGAS000115 |
Molecular analysis of Birt-Hogg-Dube syndrome: Identification of new diagnostic marker and therapeutic target |
v1:2018/05/11 |
NGS (Exome) |
Illumina (HiSeq 2000) |
15 Birt-Hogg-Dube associated kidney cancer (Japanese) |
Masahiro Yao (P-DIRECT) |
Controlled-access (Type I) |
|
Identification and functional analyses of susceptibility genes to narcolepsy and other sleep disorders |
v1:2017/12/26 |
SNP-chip |
Affymetrix (SNP Array 6.0) |
409 narcolepsy patients 1562 controls (Japanese) 125 essential hypersomnia patients 562 controls (Japanese) |
Katsushi Tokunaga |
Unrestricted-access |
|
|
Genome-wide association studies on Hepatitis C virus-related diseases and construction of genome database |
v1:2018/02/27 v2:2018/09/25 |
SNP-chip |
Affymetrix (SNP Array 6.0, Axiom ASI) |
78 NVR, 64 VR, 51 SVR 107 patients with the decrease of PLT 196 patients without the decrease of PLT 94 HCV patients with an Hb reduction 209 HCV patients without Hb reduction 123 patients who developed HCC after eradication of HCV 333 patients who did not develop HCC after eradication of HCV (Japanese) |
Yasuhito Tanaka |
Unrestricted-access |
|
|
Search for susceptibility genes to hepatitis virus B-related diseases |
v1:2017/09/25 v2:2019/02/19 v3:2022/05/27 |
SNP-chip |
Affymetrix (SNP Array 6.0, Axiom ASI) |
181 HBV carriers 185 spontaneously HBV-resolved individuals 184 controls 473 HBV-positive HCC patients 516 HBV carriers (chronic hepatitis and asymptomatic carriers) (Japanese) 329 patients with chronic HBV infection 318 healthy controls (Thailander) |
Masashi Mizokami |
Unrestricted-access |
|
|
Genome-wide search for susceptibility genes to primary biliary chirrosis |
v1:2016/10/05 |
SNP-chip |
Affymetrix (Axiom ASI) |
487 PBCs 476 controls (Japanese) |
Minoru Nakamura |
Unrestricted-access |
|
|
JGAS000068 |
Genetic analysis in neurodegeneraive disorders |
v1:2022/02/18 |
NGS (RNA-seq) |
Illumina (HiSeq 2500) |
53 inclusion body myositis patients 6 polymyositis patients 9 controls (Japanese) |
Jun Goto (Genome Science) |
Controlled-access (Type I) |
|
JGAS000120 |
Genome-wide analysis of SNPs in Healthy Japanese |
v1:2017/09/26 v1:2017/10/03 |
SNP-chip Control Set |
Affymetrix (SNP Array 6.0, Axiom ASI) |
419 Participants (Japanese) |
Katsushi Tokunaga |
Unrestricted-access Controlled-access (Type I) |
|
JGAS000070 JGAS000488 |
Genome-wide analysis for biomarker exploration (lung cancer) |
v1:2016/10/28 v2:2022/01/24 |
NGS (CAGE-seq) |
Illumina (HiSeq 2500) |
lung cancer: 97 + 38 cases malignant pleural mesothelioma: 10 cases (Japanese) |
Yoshihide Hayashizaki |
Controlled-access (Type I) |
|
JGAS000108 |
Molecular biological research affecting on long-term treatment to malignant tumors derived from the chest or abdomen Genomic analysis of environment-associated tumors |
v1:2017/10/16 v1:2018/09/25 |
Array CGH, NGS (WGS, Target Capture, Exome) |
Illumina (MiSeq, HiSeq 4000/X Ten) |
72 malignant mesotheliomas (Japanese, Americans) |
Masaki Ohmuraya |
Controlled-access (Type I) |
|
JGAS000073 JGAS000107 |
Epigenomic analysis of the human placenta and endometrium constituting the fetal-maternal interface |
v1:2017/09/25 v2:2017/12/26 v3:2018/06/26 |
NGS (PBAT-seq, ChIP-seq, RNA-seq, small RNA-seq) |
Illumina (HiSeq 1500/2500) |
placenta and uterus cells, trophoblast stem cells: total 39 samples (Japanese) |
Hiroyuki Sasaki (IHEC) |
Controlled-access (Type I) |
|
JGAS000077 JGAS000096 |
Global analysis of TGF-beta family signaling in cancer cells |
v1:2019/02/08 v2:2019/09/10 |
NGS (RNA-seq, WGS) |
Illumina (Genome Analyzer IIx) Thermo Fisher Scientific (Ion Proton) |
2 glioblastomas (Japanese) |
Kohei Miyazono |
Controlled-access (Type I) |
|
JGAS000078 JGAS000079 JGAS000080 |
Study of molecular-genetics, and molecular epidemiology for developing treatment of esophageal cancer (COC series) |
v1:2016/11/18 |
NGS (PBAT-seq, ChIP-seq, RNA-seq) |
Illumina (HiSeq 2000/2500) |
12 normal human absorptive epithelial cells (Japanese) |
Yae Kanai (IHEC) |
Controlled-access (Type I) |
|
JGAS000082 JGAS000165 JGAS000081 |
Study of molecular-genetics, and molecular epidemiology for developing treatment of esophageal cancer (GAC series) |
v1:2021/03/12 |
NGS (PBAT-seq, ChIP-seq, RNA-seq) |
Illumina (HiSeq 2000/2500) |
14 Normal human foveolar epithelial cells of the stomach (Japanese) |
Yae Kanai (IHEC) |
Controlled-access (Type I) |
|
JGAS000095 JGAS000105 JGAS000113 JGAS000128 JGAS000215 JGAS000270 JGAS000297 JGAS000335 JGAS000360 JGAS000534 |
Genomic and epigenomic analysis of different types of cancer |
v1:2017/09/04 v2:2018/01/22 v3:2019/02/12 v4:2020/08/14 v5:2020/10/26 v6:2021/01/29 v7:2021/07/02 v8:2021/10/22 v9:2021/10/26 v10:2022/05/23 v11:2022/11/08 |
NGS (WGS, Exome, RNA-seq, Target Capture, Iso-seq), Methylation array, SNP-chip |
Illumina (HiSeq 2000/2500, MethylationEPIC, HumanOmni2.5-8) 10x Genomics (Chromium Controller) PacBio (Sequel) |
68 breast cancer patients 43 + 126 lung adenocarcinoma patients 150 + 173 colorectal cancers 12 colorectal cancers with liver metastasis, 16 colorectal cancers without liver metastasis 64 desmoid tumor patients 35 pulmonary pleomorphic carcinoma patients 67 salivary duct carcinoma patients (Japanese) |
Hiroyuki Mano |
Controlled-access (Type I) |
|
JGAS000092 |
Genetic analysis of colorectal precancerous lesion and early colorectal cancer to investigate mechanism of carcinogenesis of colorectal cancer |
v1:2018/07/30 |
NGS (Exome) |
Illumina (HiSeq 2500) |
10 cases of colorectal adenomas or PCRCs (Japanese) |
Koshi Mimori |
Controlled-access (Type I) |
|
JGAS000090 JGAS000138 |
Comprehensive analysis of genetic alterations in hematological malignancies |
v1:2017/05/25 v2:2019/11/18 |
NGS (RNA-seq) Methylation array |
Illumina (HiSeq 2500, MethylationEPIC) |
123 pediatric T-ALL patients (Japanese) |
Junko Takita |
Controlled-access (Type I) |
|
JGAS000094 |
Cytogenetic analysis of hematopoietic cells in bone marrow failure syndrome |
v1:2018/05/25 |
NGS (Exome) |
Illumina (HiSeq 2500) |
5 patients with aplastic anemia with uniparental disomy in 6p (Japanese) |
Shinji Nakao (Genome Science) |
Controlled-access (Type I) |
|
JGAS000085 |
Expression quantitative trait loci analysis using human immune cells |
v1:2017/04/24 |
NGS (RNA-seq) SNP-chip |
Illumina (HiSeq 2500, Infinium OmniExpressExome) |
105 healthy volunteers (Japanese) |
Kazuhiko Yamamoto |
Unrestricted-access Controlled-access (Type I) |
|
JGAS000098 |
Identification of gene mutations in primary immunodeficiency characterized by EBV-associated B-cell lymphoma |
v1:2018/05/11 |
NGS (Target Capture) |
Illumina (MiSeq) |
2 patients with primary immunodeficiency (Japanese) |
Yasumasa Iwatani |
Controlled-access (Type I) |
|
JGAS000109 JGAS000389 |
Genome sequencing analysis for biliary tract cancer |
v1:2018/02/27 v2:2019/06/21 v3:2021/07/13 v4:2022/01/18 |
NGS (WGS, Exome, RNA-seq) |
Illumina (HiSeq 2000/2500, NovaSeq 6000) |
98 + 121 biliary tract cancers 4 normal gallbladders (Japanese) |
Hidewaki Nakagawa |
Controlled-access (Type I) |
|
JGAS000139 |
Development of the prevention and therapy of CRC using patient derived culture tissues. |
v1:2022/09/05 |
NGS (scRNA-seq) |
Illumina (HiSeq 2500) |
3 patients with colorectal cancer (patient derived culture tissues) (Japanese) |
Ryoji Yao (Genome Science) |
Controlled-access (Type I) |
|
JGAS000099 JGAS000218 |
Establish induced pluripotent stem (iPS) cells from patients with Gorlin syndrome and elucidate the pathology |
v1:2017/10/02 v2:2020/06/01 |
NGS (Exome, RNA-seq) |
Illumina (HiSeq 2500/4000) |
4 patients with Gorlin syndrome (Japanese) |
Toshifumi Azuma |
Controlled-access (Type I) |
|
JGAS000111 |
Search for new susceptibility genetic factors associated with psychiatric disorders |
v1:2017/06/26 |
Methylation array |
Illumina (HumanMethylation450) |
48 panic disorder patients 48 healthy controls (Japanese) |
Katsushi Tokunaga |
Controlled-access (Type I) |
|
JGAS000103 JGAS000141 JGAS000242 |
Analysis of gastric cancer genome and its clinicopathological significance |
v1:2017/07/31 v2:2019/05/31 v3:2021/02/19 |
NGS (RNA-seq, Amplicon-seq) |
Illumina (HiSeq 2000, MiSeq) |
30 diffuse-type gastric carcinomas 60 + 15 gastric carcinomas (Japanese) |
Shumpei Ishikawa |
Controlled-access (Type I) |
|
JGAS000112 (JGA000122) |
Basic research for the establishment and characterization of human trophoblast stem cells |
v1:2017/12/14 |
NGS (PBAT-seq, ChIP-seq, RNA-seq, miRNA-seq) |
Illumina (HiSeq 1500/2500) |
2 trophoblast stem cells (Japanese) |
Takahiro Arima |
Controlled-access (Type I) |
|
JGAS000119 JGAS000142 JGAS000318 |
Development of metabolite biomarkers of Parkinson’s disease and identification of drug seeds from chemical screening based on the biomarkers |
v1:2020/04/24 v2:2021/07/30 v3:2022/07/29 |
NGS (CAGE-seq) |
Illumina (HiSeq 2500) |
39 PD patients, 20 non-PD (healthy) contorols iPS derived neurons: 3 PD samples and 3 controls (Japanese) |
Piero Carninci |
Controlled-access (Type I) |
|
DRA007411 JGAS000314 |
Research on statistical genetics using B cell lines of Japanese ancestry |
v1:2017/12/18 v2:2019/04/12 v3:2021/08/10 |
SNP-chip NGS (Target Capture) |
Illumina (HumanCoreExome, MiSeq, HiSeq X Ten, NovaSeq) |
282 psoriasis patients 426 controls 1,173 samples (Japanese) |
Yukinori Okada |
Unrestricted-access Controlled-access (Type I) |
|
JGAS000121 DRA006296 |
Controlling cell differentiation with precision through understanding the structure and dynamics of gene regulatory networks |
v1:2020/05/15 |
NGS (RNA-seq) Microarray |
Illumina (HiSeq 2000/2500) Agilent Technologies (SurePrint G3 Human GE 8x60K v2 Microarray, SureScan G4900DA) |
TF-hESCs derived from SEES3 (Cell-line) |
Minoru S.H. Ko |
Unrestricted-access Controlled-access (Type I) |
|
JGAS000122 |
Development of hunanized mice for human immunity research |
v1:2020/11/20 |
NGS (Target Capture) |
Illumina (HiSeq 1500/2500) |
118 AMLs (Japanese) |
Fumihiko Ishikawa |
Controlled-access (Type I) |
|
JGAS000125 |
Epigenetics analysis of neurodegenerative diseases |
v1:2017/12/11 |
Methylation array |
Illumina (HumanMethylation450) |
30 Alzheimer's disease patients 30 healty controls (Japanese) |
Atsushi Iwata |
Controlled-access (Type I) |
|
JGAS000124 |
Genome-wide analysis for biomarker exploration (endometrial cancer) |
v1:2017/12/11 |
NGS (CAGE-seq) Sanger-seq |
Illumina (HiSeq 2500) Thermo Fisher Scientific (3500 Genetic Analyzer) |
17 endometrial cancer patients (Japanese) |
Yoshihide Hayashizaki |
Controlled-access (Type I) |
|
JGAS000126 |
Analysis for mechanism of onset and progress for NASH |
v1:2019/01/31 |
SNP-chip |
Illumina (Human610-Quad, HumanCoreExome, HumanOmni2.5-Quad BeadChip) |
902 NAFLDs 7672 healty controls (Japanese) |
Fumihiko Matsuda |
Controlled-access (Type I) |
|
JGAS000221 DRA011183 DRA011184 DRA011185 E-GEAD-396 DRA010902 JGAS000549 |
The genetic analysis of circulating tumor DNA in blood of the digestive cancer patients to investigate the prognostic factors of metastasis and reccurence. |
v1:2020/04/03 v2:2020/10/30 v3:2021/12/06 v4:2022/07/29 |
NGS (Exome, RNA-seq, Target Capture, WGBS) Methylation array |
Illumina (HiSeq 2500, iScan, HiSeq X Ten) |
10 + 25 + 10 colorectal cancers 16 gastric cancers 16 breast cancers (Japanese) |
Koshi Mimori |
Unrestricted-access Controlled-access (Type I) |
|
DRA006622 DRA007336 DRA008459 E-GEAD-311 |
Mutation analysis of iPS cells derived from commercially-avaialble human primary cells |
v1:2020/01/14 |
NGS (WGS) SNP-chip |
Illumina (HiSeq X Ten, Infinium Omni2.5-8) |
human iPS cells and their parental cells: total 27 samples (Cell-line) |
Ryoko Araki |
Unrestricted-access |
|
JGAS000129 |
Study for exome sequencing in familial epidermal growth factor receptor-mutant lung cancer |
v1:2018/04/06 |
NGS (Exome) |
Illumina (HiSeq 2000) |
3 EGFR-mutant lung cancers (Japanese) |
Toshiaki Kikuchi (P-DIRECT) |
Controlled-access (Type I) |
|
JGAS000127 |
Immune regulation by cotrolling regulatory T cell-specific epigenome |
v1:2018/11/05 |
NGS (RNA-seq) |
Thermo Fisher Scientific (Ion S5) |
3 Crohn's diseases 4 Colorectal cancers (normal cells) (Japanese) |
Shimon Sakaguchi |
Controlled-access (Type I) |
|
Identification of the disease and drug susceptibility genes for the Childhood Idiopathic Nephrotic Syndrome |
v1:2018/04/27 v2:2020/09/01 |
SNP-chip |
Affymetrix (Japonica Array v1/v2) |
224 + 3,206 Childhood Idiopathic Nephrotic Syndrome patients 419 + 987 healthy controls (Japanese) |
Kazumoto Iijima |
Unrestricted-access |
|
|
JGAS000130 JGAS000274 JGAS000604 JGAS000715 |
Implementation of individualized medicine for cancer patients by multiomics-based analyses—the Project HOPE (High-tech Omics-based Patients Evaluation) for Cancer Therapy— |
v1:2020/04/14 v2:2021/03/08 v3:2024/01/22 v4:2024/07/10 |
NGS (Exome, DNA Amplicon-seq, RNA Amplicon-seq, WGS) Microarray Methylation array |
Thermo Fisher Scientific (Ion Proton) Agilent Technologies (SurePrint G3 Human Gene Expression 8 × 60 K v2 Microarray, DNA Microarray Scanner) Illumina (NovaSeq 6000, Infinium MethylationEPIC array, iScan System) |
91 cancer patients with hypermutator tumors harborig POLE mutations 5143 + 7 cancer patients (Japanese) |
Ken Yamaguchi |
Controlled-access (Type I) |
|
JGAS000153 |
A study on comprehensive genome and proteome analyses of the chronic eosinophillic inflammatory diseases. |
v1:2018/10/29 |
NGS (RNA-seq) |
Illumina (HiSeq 2000) |
6 chronic rhinosinusitis with nasal polyps (Japanese) |
Shigeharu Fujieda |
Controlled-access (Type I) |
|
JGAS000131 |
Research for analyzing mechanistic insight into disease progression of neural disease based on iPS cell technology |
v1:2018/04/06 |
NGS (ChIP-seq) |
Illumina (HiSeq 2500) |
2 CHARGE syndrome patients (Japanese) |
Hideyuki Okano |
Controlled-access (Type I) |
|
JGAS000150 JGAS000289 |
Comprehensive genetic analyses of bone marrow cells in POEMS syndrome Analyses of molecular mechanisms of hematological malignancies and bone marrow niche |
v1:2019/01/18 v2:2022/09/27 v3:2024/06/17 |
NGS (Exome, Target Capture, RNA-seq, scRNA-seq) |
Illumina (HiSeq 1500/2000/2500/3000, MiSeq) |
20 + 14 POEMS syndromes 4 + 5 MMs 5 + 2 MGUSs 4 + 3 lymphomas without BM invasion (Japanese) |
Emiko Sakaida |
Controlled-access (Type I) |
|
JGAS000132 |
The epigenetics of neurodevelopmental disorders |
v1:2018/11/20 |
NGS (RNA-seq) |
Thermo Fisher Scientific (Ion Proton) |
6 Williams syndromes 8 healthy contorols (Japanese) |
Ryo Kimura |
Controlled-access (Type I) |
|
JGAS000137 |
Identification of genetic alterations in Vietnamese individuals with elevated blood dioxin level |
v1:2018/09/07 |
NGS (WGS) |
Illumina (HiSeq 2500) |
9 trios of the father exposed to dioxin and his wife and child with mental retardation (total 27 individuals) (Vietnamese) |
Hidewaki Nakagawa |
Controlled-access (Type I) |
|
JGAS000086 |
Identification of genetic mutations characteristic for recurrence and metastasis of gastric cancer. |
v1:2018/04/06 |
NGS (Exome) |
Illumina (HiSeq 2000) |
75 gastric cancers (Japanese) |
Toshiharu Yamaguchi (P-DIRECT) |
Controlled-access (Type I) |
|
JGAS000087 |
Identification of genetic mutations characteristic for recurrence and metastasis of B cell lymphoma. |
v1:2018/04/06 |
NGS (Exome) |
Illumina (HiSeq 2000) |
60 B cell lymphomas (Japanese) |
Toshiharu Yamaguchi (P-DIRECT) |
Controlled-access (Type I) |
|
JGAS000341 |
Construction of integrated clinical genome database regarding hepatitis B related diseases |
v1:2018/05/22 v2:2021/03/05 v3:2021/10/01 |
SNP-chip |
Affymetrix (Axiom ASI) |
1,193 individuals vaccinated with a HB vaccine (Bimmugen) 555 individuals vaccinated with a HB vaccine (Heptavax) (Japanese) |
Masashi Mizokami |
Unrestricted-access Controlled-access (Type I) |
|
JGAS000144 |
a multicenter study of susceptibility genes to type 1 diabetes |
v1:2018/12/21 |
NGS (Target Capture) |
Thermo Fisher Scientific (Ion Proton) |
32 type 1 diabetes patients (Japanese) |
Hiroshi Ikegami |
Controlled-access (Type I) |
|
JGAS000134 |
Clonal structure and oncogenic potential of liver cirrhosis tissues |
v1:2020/07/31 v2:2021/03/26 |
NGS (Exome, RNA-seq) |
Illumina (HiSeq 2500/4000) |
Liver cirrhosis: 10 cases Hepatocellular carcinoma: 4 cases 7 healthy donors (Japanese) |
Atsushi Takai |
Controlled-access (Type I) |
|
JGAS000136 |
Research for drug discovery and elucidation of pathophysiology using disease-specific iPS cells |
v1:2018/07/10 |
NGS (Exome) |
Illumina (HiSeq 1500) |
1 RALD patient (Japanese) |
Makoto Otsu |
Controlled-access (Type I) |
|
JGAS000158 |
Prediction of response to preoperative chemoradiotherapy in rectal cancer based on whole-exome sequencing and transcriptomic analysis |
v1:2019/11/19 |
NGS (Exome) |
Illumina (HiSeq 2000) |
74 rectal cancer treated with preoperative chemoraidotherapy (Japanese) |
Takashi Akiyoshi |
Controlled-access (Type I) |
|
JGAS000135 |
Immune regulation by cotrolling regulatory T cell-specific epigenome |
v1:2019/05/09 |
NGS (RNA-seq) |
Thermo Fisher Scientific (Ion S5) |
Head and neck cancer: 4 cases (Japanese) |
Shimon Sakaguchi |
Controlled-access (Type I) |
|
JGAS000147 |
Comprehensive analysis of genetic alterations in hematological malignancies (pediatric B-cell precursor acute lymphoblastic leukemia in Down syndrome) |
v1:2020/01/10 |
NGS (RNA-seq), Methylation array, SNP array |
Illumina (HiSeq 2000/2500, Infinium MethylationEPIC BeadChip, Infinium HumanMethylation450 BeadChip) Affymetrix (Human Mapping 250K Nsp, CytoScan HD) |
pediatric B-cell precursor acute lymphoblastic leukemia in Down syndrome: 43 cases (Japanese) |
Junko Takita |
Controlled-access (Type I) |
|
JGAS000222 |
The genetic analysis of circulating tumor DNA in blood of the digestive cancer patients to investigate the prognostic factors of metastasis and reccurence. |
v1:2020/04/03 |
NGS (Target Capture) |
Illumina (HiSeq 2500) |
10 colorectal cancers (Japanese) |
Koshi Mimori |
Controlled-access (Type I) |
|
DRA007187 |
Diagnosis of imprinting disorders and safety evaluation of assisted reproduction technologies (ART) |
v1:2019/02/19 |
NGS (RRBS) |
Illumina (HiSeq 2500) |
5 SRS patients born after ART 5 spontaneously conceived SRS patients 10 spontaneously conceived children (Japanese) |
Takahiro Arima |
Unrestricted-access |
|
JGAS000145 JGAS000312 JGAS000454 |
Immune regulation by cotrolling regulatory T cell-specific epigenome |
v1:2020/05/25 v2:2022/02/18 v3:2023/05/08 |
NGS (RNA-seq, ChIP-seq, PBAT-seq, ATAC-seq, scRNA-seq) |
Thermo Fisher Scientific (Ion S5) Illumina (HiSeq 2500/3000/4000, NovaSeq 6000) |
4 + 1 healty donors 7 + 3 cancer patients (Japanese) |
Shimon Sakaguchi |
Controlled-access (Type I) |
|
JGAS000149 |
Analysis of abnomal character and expression of genes in tissues of urologic carcinomas. |
v1:2019/06/20 |
NGS (RNA-seq) |
Illumina (Genome Analyzer IIx) |
67 renal cell carcinomas (Japanese) |
Takeshi Yuasa |
Controlled-access (Type I) |
|
JGAS000182 JGAS000529 |
Multi‐institutional study on molcular pathogenesis of bone and soft tissue tumors by genome and proteome analyses and its clinical application |
v1:2019/09/20 v2:2022/11/15 |
NGS (WGS, Exome, RNA-seq) |
Illumina (HiSeq 2500, NovaSeq 6000) |
Dedifferentiated liposarcoma: 37 cases lipoblastoma-like tumor of the vulva: 1 case (Japanese) |
Hitoshi Ichikawa |
Controlled-access (Type I) |
|
JGAS000177 |
Multiomics analysis of rare cancers to identify genetic alterations related with pathogenesis and prognosis |
v1:2019/09/20 |
NGS (Exome, RNA-seq, Target Capture) |
Illumina (HiSeq 2500, MiSeq) |
28 Dedifferentiated liposarcoma patients 36 Tendon sheath giant cell tumor patient (Japanese) |
Koichi Matsuda |
Controlled-access (Type I) |
|
JGAS000227 |
Integrative genetic analysis using next generation sequencer reveals mechanisms of resistance to chemoradiotherapy for esophageal cancer |
v1:2021/07/30 |
NGS (Exome) |
Illumina (HiSeq 2500) |
33 esophageal cancer patients (Japanese) |
Koshi Mimori |
Controlled-access (Type I) |
|
JGAS000164 |
Cancer clinical sequence and accompanying research for comprehensive genomic and epigenomic analyses |
v1:2019/08/19 |
NGS (Target Capture) |
Illumina (NextSeq) |
183 cancer patients (Japanese) |
Kohei Miyazono |
Controlled-access (Type I) |
|
JGAS000151 |
Genome sequencing analysis for liver cancer |
v1:2018/10/22 v2:2019/06/21 v3:2021/07/13 |
NGS (WGS, RNA-seq) |
Illumina (HiSeq 2000, Genome Analyzer IIx, NovaSeq 6000) |
263 liver cancers (Japanese) |
Hidewaki Nakagawa |
Controlled-access (Type I) |
|
JGAS000157* |
Genome sequencing analysis for colorectal cancer |
v1:2021/06/01 v2:2022/12/27 |
NGS (WGS) |
Illumina (Hiseq 2000) |
10 colorectal cancers (Japanese) |
Hidewaki Nakagawa |
Controlled-access (Type I) |
|
JGAS000155 |
Genome sequencing analysis for esophageal squamous cell carcinoma |
v1:2019/05/28 v2:2021/07/13 |
NGS (WGS) |
Illumina (HiSeq 2000/2500/X Five) |
20 esophageal squamous cell carcinomas (Japanese) |
Hidewaki Nakagawa |
Controlled-access (Type I) |
|
JGAS000156* |
Genome sequencing analysis for hepatoblastoma |
v1:2021/06/04 v2:2022/12/27 |
NGS (WGS) |
Illumina (Hiseq 2500) |
33 hepatoblastomas (Japanese) |
Hidewaki Nakagawa |
Controlled-access (Type I) |
|
Pharmacogenomics research for therapeutics in psychiatry, neurology and oncology |
v1:2018/12/14 v2:2021/02/09 v3:2023/04/21 |
NGS (Target Capture) SNP-chip |
Illumina (MiSeq, Infinium OmniExpressExome) |
990 patients with psychiatric/neurological disorders and cancers 90 bullous pemphigoid cases 737 healthy controls (Japanese) |
Taisei Mushiroda |
Unrestricted-access |
|
|
JGAS000160 |
Tohoku Medical Megabank Organization cohort study |
v1:2018/12/14 |
SNP-chip |
Illumina (Infinium OmniExpressExome-8) |
9,187 participants (Japanese) |
Masao Nagasaki |
Controlled-access (Type I) |
|
JGAS000162 |
Genetic analysis of familial myelodysplastic syndromes |
v1:2019/05/07 |
NGS (Exome) |
Illumina (HiSeq 2500) |
2 patients of familial myelodysplastic syndromes (Japanese) |
Junji Koya |
Controlled-access (Type I) |
|
Multicenter Evaluation of NUDT15-R139C genotyping efficiency to DEtect thiopurine-induced hair Loss and leukopenia (MENDEL study) |
v1:2019/07/30 v2:2024/01/25 |
SNP-chip |
Affymetrix (Japonica Array v1) |
1221 + 2680 patients of Inflammatory bowel disease (Japanese) |
Yoichi Kakuta |
Unrestricted-access Controlled-access (Type I) |
|
|
Study to clarify the pathophysiology of gout / hyperuricemia and uric acid related diseases |
v1:2019/07/23 |
SNP-chip |
Illumina (HumanOmniExpressExome-8, Human660W-Quad, HumanOmni2.5-8, HumanOmniExpress-12, HumanOmniExpress-24, HumanOmniExpressExome, HumanOmniExpress, HumanExome) |
121,745 participants of 3 Japanese cohorts (J-MICC study, KING study, BBJ) (Japanese) |
Hirotaka Matsuo |
Unrestricted-access |
|
|
JGAS000169 |
Comprehensive genomic analyses of cancers |
v1:2019/11/08 |
NGS (Exome) |
Illumina (HiSeq 2500) |
51 adenomyosis patients (Japanese) |
Masahito Kawazu |
Controlled-access (Type I) |
|
JGAS000178 |
Molecular analysis to identify novel biomarker and therapeutic target for cerebrospinal tumor and preclinical investigation using patient derived orthotopic xenograft models. |
v1:2019/06/01 v2:2020/07/17 |
NGS (Exome) |
Illumina (HiSeq 2500) |
9 PCNSL patinets (Japanese) |
Tetsuya Yamamoto |
Controlled-access (Type I) |
|
JGAS000171 |
A Study on the Health and Development of Children Beginning in the Fetal Period |
v1:2019/04/23 |
NGS (RRBS) |
Illumina (NextSeq) |
human umbilical cords: 30 samples (Japanese) |
Chisato Mori |
Controlled-access (Type I) |
|
JGAS000173 JGAS000580 JGAS000286 JGAS000505 JGAS000596 |
Building a Database of Genomic Structural Variants in Japanese population |
v1:2020/10/06 v2:2020/11/27 v3:2023/06/29 v4:2023/07/06 v5:2023/07/10 v6:2023/12/28 |
NGS (WGS) |
PacBio (Sequel, Sequel II) 10x Genomics (Chromium Controller) Nanopore (PromethION) |
Purified DNA from Japanese-origin B cell lines: 10 + 11 + 177 + 141 + 30 samples |
Shinichi Morishita |
Controlled-access (Type I) |
|
JGAS000174 JGAS000642 |
Development of actionable molecular targets and/or biomarkers for prognostication and patient stratification in gynecological cancer based on whole-exome sequencing and epigenomic analysis |
v1:2019/10/02 v2:2024/03/01 |
NGS (Exome, Target Capture) |
Illumina (HiSeq 2000) |
69 endometrial carcinomas 30 endometrial hyperplasia patients (Japanese) |
Nobuhiro Takeshima |
Controlled-access (Type I) |
|
JGAS000172 |
Comprehensive sequencing analyses of uterine and ovarian carcinosarcoma |
v1:2019/10/02 |
NGS (Exome, Target Capture) |
Illumina (HiSeq 2000) |
92 uterine carcinosarcomas 17 ovarian carcinosarcomas (Japanese) |
Seiichi Mori |
Controlled-access (Type I) |
|
JGAS000197 |
Genetic analysis assciated with malignance of brain tumor |
v1:2020/04/27 |
NGS (PBAT-seq, RNA-seq, ChIP-seq) |
Illumina (HiSeq X Ten, NovaSeq 6000) |
14 malignant gliomas (Japanese) |
Takashi Ito |
Controlled-access (Type I) |
|
JGAS000186 DRA009794 |
Shotgun metagenome analysis of oral microbiome in MRONJ and healthy individuals |
v1:2020/04/03 |
Metagenome |
Nanopore (PromethION) Illumina (HiSeq) |
4 healthy individuals (Japanese) |
Koji Yahara (Genome Science) |
Unrestricted-access Controlled-access (Type I) |
|
JGAS000170 |
Genetic study and evaluation of small molecule compounds for congenital diseases and metabolic disorders caused by an aberrant RNA splicing |
v1:2021/03/12 |
NGS (RNA-seq) |
Thermo Fisher Scientific (Ion Proton) |
Familial Dysautonomia: 2 cases |
Masahiko Ajiro |
Controlled-access (Type I) |
|
Aging of steroid production in the adrenal bland. |
v1:2019/09/25 |
Immunohistochemistry |
Dako (Autostainer Link 48) |
85 anatomical cases who were more than 50 years old (Japanese) |
Koshiro Nishimoto |
Unrestricted-access |
|
|
JGAS000180 DRA008482 JGAS000516 |
Comprehansive analysis of somatic mutations and genetic variations with whole genome sequencing |
v1:2019/06/20 v2:2020/05/12 v3:2021/01/06 v4:2021/11/12 v5:2022/05/27 |
NGS (WGS, RNA-seq) |
Nanopore (MinION) Illumina (HiSeq 2000, Genome Analyzer IIx) |
liver cancer (normal cell): 174+42 case liver cancer (tumor tissue): 11+42 cases HapMap: 1 sample (Japanese) Breast cancer: 1 sample (Cell-line) |
Akihiro Fujimoto |
Unrestricted-access Controlled-access (Type I) |
|
JGAS000239 |
Construction of Japanese Whole-Genome database |
v1:2020/09/01 v2:2022/02/18 |
NGS (WGS) |
Illumina (HiSeq 2500, NovaSeq 6000) |
4,566 general residents (Japanese) |
Masayuki Yamamoto |
Controlled-access (Type II) |
|
JGAS000194 JGAS000233 |
Genomic and genetic analysis of digestive tract cancer and elucidation of its clinicopathological significance. |
v1:2020/05/12 v2:2021/05/31 |
NGS (Target Capture, Exome, RNA-seq), Methylation array |
Illumina (MiSeq, HiSeq 2500, HumanMethylation450) |
243 + 160 hepatocellular carcinomas (Japanese) |
Hiroyuki Aburatani |
Controlled-access (Type I) |
|
JGAS000179 |
Exploration for molecular targets in gastric cancer cell lines |
v1:2019/06/28 |
NGS (Exome, RNA-seq) |
Illumina (HiSeq 2500) |
2 gastric cancer cell lines (Cell-line) |
Hiroyuki Mano |
Controlled-access (Type I) |
|
DRA008575 |
Development of personalized cancer vaccine targeting individual somatic mutations combined with immunoregulation of tumor microenvironment |
v1:2020/06/05 |
NGS (RNA-seq) |
Illumina (HiSeq 1500/4000) |
Pancreatic cancer: 17 cases (Japanese) |
Kazuhiro Kakimi |
Unrestricted-access |
|
JGAS000196 |
A study to verify the usefulness of cell free DNA as a prognostic biomarker after radiation / proton therapy for oligometastasis in colorectal cancer patients |
v1:2021/04/23 |
NGS (Target Capture) |
Illumina (NovaSeq 6000) |
Colon cancer: 20 cases (Japanese) |
Masaki Nakamura |
Controlled-access (Type I) |
|
JGAS000189 |
Molecular mechanisms of drug resistance in cancer |
v1:2020/05/11 |
NGS (Target Capture) |
Illumina (MiSeq) |
2 lung adenocarcinomas (Japanese) |
Ryohei Katayama |
Controlled-access (Type I) |
|
JGAS000190 JGAS000234 JGAS000269 |
Comprehensive genetic analysis of gastrointestinal and hepatobiliary tumor |
v1:2021/03/26 v2:2022/02/28 v3:2022/03/18 |
NGS (WGS, Exome, RNA-seq, Target Capture) |
Illumina (HiSeq 4000, NovaSeq 6000) Thermo Fisher Scientific (Ion Proton) |
5 nodule-in-nodule hepatocellular carcinomas 20 liver cirrhosis and hepatocellular carcinomas after hepatitis C virus eradication 3 hepatitis C virus positive cirrhosis and hepatocellular carcinomas 2 hepatitis C virus negative hepatocellular carcinomas 42 + 1 patients with gastric cancer and 3 patients with gastric submucosal tumor (Japanese) |
Atsushi Takai |
Controlled-access (Type I) |
|
Identification of biomarker for suicide prevention using blood and brain samples of completed suicide |
v1:2019/12/20 |
SNP-chip |
Illumina (HumanOmniExpress-24, HumanOmniExpressExome-8) |
Suicide: 746 cases Non-suicide: 14,049 cases (Japanese) |
Akitoyo Hishimoto |
Unrestricted-access |
|
|
JGAS000205 JGAS000260 JGAS000316 JGAS000415 JGAS000504 JGAS000530 JGAS000531 JGAS000543 DRA014184 DRA014186 DRA014188 DRA014191 DRA014192 JGAS000593 JGAS000600 JGAS000741 JGAS000751 |
Elucidation of disease state by multi-layered omics analysis |
v1:2019/11/15 v2:2020/11/27 v3:2021/03/22 v4:2021/12/10 v5:2021/12/21 v6:2022/02/08 v7:2022/05/23 v8:2022/06/03 v9:2022/06/10 v10:2022/06/16 v11:2022/07/21 v12:2022/12/01 v13:2023/02/14 v14:2023/02/16 v15:2023/03/29 v16:2023/06/06 v17:2023/06/27 v18:2023/10/02 v19:2024/05/29 v20:2024/05/30 v21:2024/10/28 v22:2024/11/11 |
Metagenome SNP-chip NGS (WGS, RNA-seq, scRNA-seq) Presence or absence of endogenous herpesvirus 6, anellovirus load |
Illumina (HiSeq 2500/3000/X Ten, NovaSeq 6000, Asian Screening Array, HumanOmniExpressExome, HumanOmniExpress, HumanExome, iCOGS OncoArray) Applied Biosystems (UK BiLEVE Axiom Array, UK Biobank Axiom Array) Thermo Fisher Scientific (FinnGen1 ThermoFisher Array or other genotyping arrays) MGI (DNBSEQ-T7) |
95 + 103 + 227 + 30 + 141 + 136 + 88 + 5 + 524 Japanese individuals BBJ: 180,215 individuals UK biobank: 377,583 individuals FinnGen: 136,000 + 224,352 individuals BACC: 247,173 individuals PRACTICAL: 140,254 individuals Autoimmune pulmonary alveolar proteinosis: 198 cases Control participants: 395 Ulcerative Colitis: 35 cases Crohn's disease: 39 cases Healthy controls: 40 individuals Intracranial germ cell tumors: 133 cases Control participants: 762 COVID-19: 30 + 43 cases Healthy controls: 31 + 44 individuals Healthy subjects: 73 individuals Hunner-type interstitial cystitis: 144 cases Type 2 diabetes: 27,642 cases (BBJ) Control participants: 70,242 (BBJ) Type 2 diabetes: 27,642 cases (UK biobank) Control participants: 70,242 (UK biobank) Recurrent pregnancy loss: 1,728 cases Autoimmune diseases: 2,238 cases Control participants: 2,919 HPV-associated oropharyngeal cancer: 32 cases Non-HPV-associated oropharyngeal cancer: 17 cases Control participants: 2 (Japanese, British, Finnish) |
Yukinori Okada |
Unrestricted-access Controlled-access (Type I) |
|
JGAS000198 |
Identification of therapeutic target molecules in urological malignancies by using next generation sequencer |
v1:2020/06/29 |
NGS (RNA-seq) |
Illumina (HiSeq 2500) |
Prostate cancer: 25 cases (Japanese) |
Tetsuya Fujimura |
Controlled-access (Type I) |
|
JGAS000202 JGAS000265 JGAS000290 JGAS000387 |
Analysis of somatic mutations and gene expression abnormalities involved in mammary tumor phenotype |
v1:2021/03/29 v2:2021/05/07 v3:2021/10/01 v4:2022/03/02 v5:2022/08/29 |
NGS (Exome, WGS, Target Capture, Visium Spatial Gene Expression, semibulk RNA-seq, scRNA-seq) CNV Methylation analysis Histological image |
Illumina (HiSeq 3000, NovaSeq 6000) 10x Genomics (Chromium Controller) Nanopore (PromethION) |
96 Ductal Carcinoma In Situ 4 Invasive Ductal Carcinoma (Japanese) |
Satoi Nagasawa (Genome Science) |
Controlled-access (Type I) |
|
JGAS000199 JGAS000237* JGAS000256 JGAS000378 JGAS000350 JGAS000550 JGAS000719 |
Collection and transfer of human tumor samples and research using genomic information Transfer of existing samples and research using genomic information Reseach of searching gene mutations in gastrointestinal chronic inflammatory diseases |
v1:2019/12/20 v2:2020/10/06 v3:2020/11/20 v4:2021/11/19 v5:2022/06/06 v6:2022/08/05 v7:2022/12/27 v8:2024/08/28 |
NGS (Exome, WGS, RNA-seq, ChIP-seq, scRNA-seq, ATAC-seq) |
Illumina (HiSeq 2500/4000/X Ten, NovaSeq 6000) |
gastrointestinal inflammatory disease: 29 cases gastrointestinal inflammatory disease with neoplastic disease: 26 cases control patients who underwent colonoscopy: 16 individuals neoplastic disease: 23 + 1 + 4 + 2 + 3 cases pancreatic cancer: 50 cases (Japanese) |
Toshiro Sato |
Controlled-access (Type I) |
|
JGAS000379 |
Study of genetic background and time course of congenital hearing loss to increase efficacy of auditory, speech, and language therapy. |
v1:2022/09/09 |
NGS (Exome) |
Illumina (HiSeq 2500/4000) |
3 congenital hearing loss patients and their parents (Japanese) |
Tatsuo Matsunaga |
Controlled-access (Type I) |
|
JGAS000206 |
Establishment of an integrated database for clinical and genomic data in cancer |
v1:2020/06/01 |
NGS (Target Capture) |
Illumina (HiSeq 2500) |
154 patients with multiple myeloma (Japanese) |
Keizo Horibe |
Controlled-access (Type I) |
|
JGAS000207 |
Establishment and characterization of cell lines derived from pregnancy related diseases |
v1:2019/11/26 |
NGS (PBAT-seq, RNA-seq) |
Illumina (HiSeq 1500/2500) |
complete hydatidiform mole: 3 cases (Japanese) |
Takahiro Arima |
Controlled-access (Type I) |
|
Analysis of gene polymorphism and gene expression in human immune cells |
v1:2020/01/06 |
NGS (RNA-seq, ChIP-seq, Hi-C) eQTL |
Illumina (HiSeq 2500, HiSeq series, Infinium OmniExpressExome) |
rheumatoid arthritis: 30 cases osteoarthritis: 30 cases (Japanese) |
Keishi Fujio |
Unrestricted-access |
|
|
JGAS000214 |
Comprehensive genetic analysis and database construction for head and neck cancer |
v1:2020/01/20 |
NGS (Exome) |
Illumina (HiSeq X Ten) |
10 patients with cancer of the external auditory canal (Japanese) |
Takashi Nakagawa |
Controlled-access (Type I) |
|
Genetic and clinical prediction models for the efficacy and hepatotoxicity of methotrexate in patients with rheumatoid arthritis: a multicenter cohort study |
v1:2019/12/13 |
SNP-chip Direct sequencing |
Thermo Fisher Scientific (GeneChip® Scanner 3000 7G) Applied Biosystems (Veriti 96-Well Thermal Cycler and 3730XL DNA Analyzer) |
Rheumatoid arthritis: 166 cases (Japanese) |
Shunichi Kumagai |
Unrestricted-access |
|
|
JGAS000211 |
Comprehensive genomic analysis of hematological malignancies |
v1:2020/04/06 |
NGS (Exome) |
Illumina (NextSeq 500) |
1 patient with concomitant acute myeloid leukemia and mediastinal germ cell tumor (Japanese) |
Kazuya Shimoda |
Controlled-access (Type I) |
|
JGAS000238 |
Demographic History and Local Adaptation in Asian Population |
v1:2022/07/15 |
NGS (WGS) |
Illumina (HiSeq X Ten) |
60 Baltis individuals |
Min-Sheng Peng |
Controlled-access (Type I) |
|
JGAS000220 JGAS000296 E-GEAD-397 E-GEAD-398 E-GEAD-420 JGAS000486 JGAS000598 JGAS000485 JGAS000626 JGAS000627 JGAS000648 |
Integrative understanding of human immune system by functional genomics and development of intervention strategies for the prevention of autoimmune diseases |
v1:2020/10/09 v2:2021/03/05 v3:2021/04/28 v4:2022/01/21 v5:2022/03/09 v6:2022/08/25 v7:2023/03/28 v8:2023/07/06 v9:2024/02/08 |
NGS (RNA-seq, scRNA-seq) eQTL BCR repertoire analysis |
Illumina (HiSeq 2500, NovaSeq 6000) |
10 Immune-mediated diseases: 544 cases 185 normal controls (Japanese) |
Keishi Fujio |
Unrestricted-access Controlled-access (Type I) |
|
JGAS000532 |
Whole genome and RNA analysis of geriatric disease in Japanese |
v1:2022/09/28 |
NGS (RNA-seq) |
Illumina (NovaSeq 6000) |
Alzheimer's disease: 317 cases Mild cognitive impairment: 432 cases 107 Healthy controls (Japanese) |
Kouichi Ozaki |
Controlled-access (Type I) |
|
JGAS000216 JGAS000244 JGAS000279 |
Analyses of immune status of patients with solid tumors including gastrointestinal cancer Investigation of anti-tumor immunological response in solid tumors |
v1:2020/02/07 v2:2020/09/25 v3:2021/03/29 v4:2021/04/13 |
NGS (Exome) |
Illumina (HiSeq 2500, NovaSeq 6000) |
17 patients with lung adenocarcinoma 26 + 23 patients with gastric cancer 9 patients with lung cancer 5 patients with malignant melanoma 7 patients with cololectal cancer (Japanese) |
Hiroyoshi Nishikawa |
Controlled-access (Type I) |
|
JGAS000217 |
Identification of genetic alterations predicting cancer progression from colorectal polyps |
v1:2020/03/02 |
NGS (Target Capture) |
Thermo Fisher Scientific (Ion Torrent) |
50 colorectal serrated lesions (Japanese) |
Takeshi Sawada |
Controlled-access (Type I) |
|
E-GEAD-344 |
Gene expression analysis in systemic sclerosis |
v1:2020/10/09 |
NGS (scRNA-seq) |
Illumina (HiSeq) |
Systemic sclerosis: 3 cases (Japanese) |
Keishi Fujio |
Unrestricted-access |
|
JGAS000223 |
A study of influence of storage condition after blood collection on the plasma/serum comcentrations of compounds |
v1:2020/06/02 |
LC-MS/MS |
Sciex (TripleTOF 5600) |
3 heathy individuals (Japanese) |
Sumio Ohtsuki (AMED-Metabolites) |
Controlled-access (Type I) |
|
JGAS000225 |
Genetic study using human disease-specific iPS cells |
v1:2023/07/28 |
NGS (RNA-seq) |
Illumina (NovaSeq 6000) |
iPS cells derived from Fabry disease patients: 3 samples (Cell-line) |
Yohei Hayashi |
Controlled-access (Type I) |
|
JGAS000224 |
Identification of responsible genes and development of standardized medicine for familial breast cancer by genetic analysis with NGS technology |
v1:2020/03/13 |
NGS (Target Capture) |
Illumina (HiSeq 2000) |
115 breast cancer patients (Japanese) |
Shinji Ohno |
Controlled-access (Type I) |
|
JGAS000232 |
The analyses of gene mutations in hematology malignancy |
v1:2020/09/01 |
NGS (Target Capture) |
Thermo Fisher Scientific (Ion Proton) |
7 patients with multiple myeloma (Japanese) |
Yasuhito Terui |
Controlled-access (Type I) |
|
JGAS000226 |
Mortality and risk of progression to adult T-cell leukemia/lymphoma in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis |
v1:2020/05/08 |
NGS (Target Capture) |
Illumina (HiSeq 2500/3000) |
HAM: 21 cases (Japanese) |
Makoto Yamagishi |
Controlled-access (Type I) |
|
JGAS000229 |
Genomic and genetic analysis of upper gastrointestinal tumors and elucidation of its clinicopathological significance. |
v1:2021/06/04 |
NGS (Exome, RNA-seq) |
Illumina (HiSeq 2500) |
141 stomach adenocarcinomas (Japanese) |
Hiroyuki Aburatani |
Controlled-access (Type I) |
|
JGAS000228 |
Genomic and genetic analysis of gastric tumors and elucidation of its clinicopathological significance. |
v1:2021/06/04 |
NGS (Exome, RNA-seq) |
Illumina (HiSeq 2500) |
102 stomach adenocarcinomas (Japanese) |
Hiroyuki Aburatani |
Controlled-access (Type I) |
|
JGAS000230 |
Identification and characterization of molecular markers in aging and neuronal disorders |
v1:2020/05/15 |
NGS (scRNA-seq) |
Illumina (HiSeq 2500) |
7 supercentenarians 2 family members 2 unrelated donors (Japanese) |
Piero Carninci |
Controlled-access (Type I) |
|
JGAS000287 |
A study for the establishment of disease-specific iPS cells. |
v1:2024/07/22 |
NGS (Exome) |
Illumina (HiSeq 2500) |
120 Healthy volunteers (Japanese) |
Megumu K. Saito |
Controlled-access (Type I) |
|
JGAS000231 |
Evaluation of metastasis and recurrence by monitoring circulating tumor DNA of gastric cancer |
v1:2020/06/01 |
NGS (Target Capture) |
Illumina (HiSeq 2000) |
10 gastric cancer patients (Japanese) |
Satsoshi Nishizuka |
Controlled-access (Type I) |
|
JGAS000236 |
Paediatric Hepatic International Tumour Trial (JPLT4: PHITT) |
v1:2021/05/31 |
NGS (Exome, RNA-seq, WGBS) SNP-chip Methylation array |
Illumina (HiSeq 2500, HumanMethylation450) Affymetrix (SNP Array 6.0) |
165 pediatric hepatoblastomas (Japanese) |
Eiso Hiyama |
Controlled-access (Type I) |
|
JGAS000272 |
Evaluation and imaging study of the preclinical stage of Alzheimer's disease in Japan |
v1:2021/04/06 |
Neuroimage Clinical Info |
25 healthly controls 3 preclinical AD 7 early MCI 5 late MCI (Japanese) |
Hiroyuki Shimada |
Unrestricted-access Controlled-access (Type I) |
|
|
JGAS000245 |
Development of tumor infiltrating lymphocytes therapy targeting gene mutation of lung cancer |
v1:2020/12/14 |
NGS (Exome, RNA-seq) |
Illumina (HiSeq 2500) Nanopore (MinION) |
7 non-small cell lung cancer patients (Japanese) |
Tetsuya Nakatsura |
Controlled-access (Type I) |
|
Whole genome and RNA analysis of geriatric disease in Japanese |
v1:2021/03/05 |
SNP-chip |
Affymetrix (Japonica Array, SNP Array 6.0) |
Alzheimer's disease: 3,962 cases 4,074 controls (Japanese) |
Kouichi Ozaki |
Unrestricted-access |
|
|
JGAS000240 |
Development of personalized medicine |
v1:2020/07/28 |
NGS (WGS) |
Illumina (HiSeq 2500) |
3 participants of BBJ (Japanese) |
Yukihide Momozawa |
Controlled-access (Type I) |
|
JGAS000241 |
Genomic and Proteomic comprehensive analysis related to cancer, infectious diseases, intractable diseases and lifestyle-related diseases |
v1:2020/07/27 |
NGS (Target Capture) |
Thermo Fisher Scientific (Ion Proton) |
19 patients with urothelial bladder cancer (Japanese) |
Yosuke Hirotsu |
Controlled-access (Type I) |
|
JGAS000258 |
Whole genome sequence analysis in patients with primary central nervous system lymphomas |
v1:2020/10/30 |
NGS (Target Capture) |
Thermo Fisher Scientific (Ion Torrent) |
28 PCNSL patinets (Japanese) |
Ryuya Yamanaka |
Controlled-access (Type I) |
|
JGAS000243 |
Frequent post-treatment monitoring of colorectal cancer using individualized ctDNA validated by multi-regional molecular profiling |
v1:2021/01/05 |
NGS (Target Capture) |
Illumina (HiSeq 2000) |
12 colorectal cancer patients (Japanese) |
Satsoshi Nishizuka |
Controlled-access (Type I) |
|
JGAS000253 |
Development of humanized mice for human immunity research/Construction of disease and treatment model using iPS cells derived from human hematopoitec cells. |
v1:2020/11/20 |
NGS (RNA-seq, CAGE-seq) |
Illumina (HiSeq 2500) |
Cord blood: 24 individuals Acute Myeloid Leukemia: 116 cases (Japanese) |
Fumihiko Ishikawa |
Controlled-access (Type I) |
|
JGAS000276 |
Comprehensive Genome analysis of adult acute lymphoblastic leukemia (JALSG ALL202U-GWS) |
v1:2022/10/25 |
NGS (Target Capture) |
Illumina (HiSeq 2500) |
46 patients with Ph-negative ALL (Japanese) |
Fumihiko Hayakawa |
Controlled-access (Type I) |
|
JGAS000249 DRA010773 |
Research for gene mutations in cancer representing immune status of the patients |
v1:2021/01/04 |
NGS (Exome) |
Illumina (HiSeq 1500) |
3 malignant melanoma patients (Japanese) |
Takashi Iwata |
Unrestricted-access Controlled-access (Type I) |
|
JGAS000259 |
Establishment of a Japanese reference genome sequence by high-precision long-read sequencing |
v1:2020/10/30 v2:2020/11/06 |
NGS (WGS) |
PacBio (RS II) Bionano (Irys, Saphyr) Illumina (HiSeq 2500) |
3 Japanese male individuals (Japanese) |
Masayuki Yamamoto |
Unrestricted-access Controlled-access (Type II) |
|
JGAS000248 |
Elucidation of pathological conditions and development of therapeutic methods using iPS cells derived from patients with hard tissue/connective tissue related diseases |
v1:2020/09/01 |
NGS (CAGE-seq) |
Illumina (NextSeq 500) |
3 patients with hard tissue/connective tissue related diseases (Japanese) |
Toshifumi Azuma |
Controlled-access (Type I) |
|
JGAS000277 |
Brain Mapping by Integrated Neurotechnologies for Disease Studies: Human Brain Aging Imaging Study |
v1:2021/03/29 |
Neuroimage Clinical Info |
11 MCI 28 healthly controls (Japanese) |
Takeshi Iwatsubo |
Controlled-access (Type I) |
|
|
JGAS000278 |
Phase II clinical trial of adult Philadelphia chromosome-negative precursor B-cell acute lymphocytic leukemia with combination chemotherapy |
v1:2022/10/25 |
NGS (RNA-seq, Target Capture) |
Illumina (HiSeq 2500) |
153 patients with Ph-negative B-ALL (Japanese) |
Yoshihiro Hatta |
Controlled-access (Type I) |
|
JGAS000301 JGAS000553 |
Study for molecular characteristics of adult T-cell leukemia-lymphoma and HTLV-1-associated diseases |
v1:2021/07/12 v2:2023/12/06 v3:2024/03/04 |
NGS （Target Capture, RNA-seq, scRNA-seq, WGS, scATAC-seq, ChIP-seq） |
Illumina (HiSeq 2500/3000, NovaSeq 6000, NextSeq 500） MGI (DNBSEQ-G400) |
ATL: 6 + 4 + 6 cases (Japanese) HTLV-1 infected carriers: 10 cases (Japanese) CD4+ T cells from 3 + 1 healthy donors (Cell-line) |
Makoto Yamagishi |
Controlled-access (Type I) |
|
JGAS000257 |
Development of sequencing library preparation method from cell-free DNA in blood |
v1:2021/09/24 |
NGS (WGS) |
Illumina (MiSeq, HiSeq X Ten) |
5 healthy individuals (Japanese) |
Fumihito Miura |
Controlled-access (Type I) |
|
JGAS000262 JGAS000263 JGAS000264 JGAS000514 E-GEAD-414 E-GEAD-415 E-GEAD-416 E-GEAD-417 GSE202023 |
Development of culturing methods amplifying micro-specimens derived from human pancreas and biliary tract tissues |
v1:2021/12/24 v2:2023/01/10 |
NGS (Exome, RNA-seq, ATAC-seq, ChIP-seq, Hi-C) |
Illumina (NovaSeq 6000, HiSeq 2500, NextSeq 500) |
Pancreatic ductal adenocarcinoma: 17 cases Intraductal papillary mucinous neoplasm: 6 cases (Japanese) |
Keisuke Tateishi (Genome Science) |
Unrestricted-access Controlled-access (Type I) |
|
Genome-wide association study of primary biliary cholangitis (PBC) －an additional study of 1,000 Japanese PBC patients－ |
v1:2021/01/08 v2:2021/01/19 |
SNP-chip |
Affymetrix (Axiom ASI, Japonica Array v1) |
1,953 PBCs and 3,690 healthy controls (Japanese) |
Minoru Nakamura |
Unrestricted-access |
|
|
JGAS000267 |
Identification of biomarkers for prediction of efficacy of microtubule inhibitors and antifolates in non-small cell lung cancer |
v1:2021/05/11 |
NGS (RNA-seq) |
Illumina (HiSeq 1500/2500) |
Lung Adenocarcinoma: 24 cases (Japanese) |
Katsuya Tsuchihara |
Controlled-access (Type I) |
|
JGAS000292 |
Comprehensive analysis of the abnormality of the genes in juvenile myelomonocytic leukemia |
v1:2023/07/24 |
NGS (DREAM-seq) |
Illumina (HiSeq 2500) |
Juvenile myelomonocytic Leukemia: 149 cases (Japanese) |
Yoshiyuki Takahashi |
Controlled-access (Type I) |
|
JGAS000508 |
Elucidation of the pathogenesis and identification of susceptibility genes for sleep disorders by genetic and functional analyses. |
v1:2022/02/07 v2:2022/02/28 |
SNP-chip |
Affymetrix (SNP Array 6.0) |
Idiopathic hypersomnia: 129 cases (Japanese) |
Makoto Honda |
Unrestricted-access Controlled-access (Type I) |
|
JGAS000281 |
Elucidation of the pathogenesis of autoimmune dermatosis using patient samples. |
v1:2022/12/27 |
NGS (scRNA-seq) |
Illumina (NovaSeq 6000) |
3 patients with pemphigus 3 healthy controls (Japanese) |
Shohei Egami |
Controlled-access (Type I) |
|
JGAS000280 |
Direct and comprehensive identification of neoantigens using cancer tissues |
v1:2021/04/09 |
NGS (Iso-seq, CAGE-seq, RNA-seq) |
Illumina (NextSeq 500, NovaSeq 6000) PacBio (Sequel) |
Human colon cancer cell line: 1 sample (Cell-line) Colon cancer: 6 patients (Japanese) |
Takayuki Kanaseki |
Controlled-access (Type I) |
|
JGAS000295 JGAS000565 JGAS000566 JGAS000567 |
Sensitive gene analysis of hereditary cardiovascular disease |
v1:2021/05/25 v2:2024/03/18 |
NGS (Exome, RNA-seq) |
Illumina (HiSeq 2500/3000) |
hereditary cardiovascular disease: 13 + 20 cases (Japanese) |
Yoshihiro Asano |
Controlled-access (Type I) |
|
JGAS000282 |
Translational research for elucidating molecular and pathological abnormalities specific to bone and soft tissue tumors based on genomic and genetic analysis, and for developing new diagnostic and therapeutic strategies |
v1:2022/05/19 |
NGS (Target Capture) |
Thermo Fisher Scientific (Ion Proton) |
16 pediatric Osteosarcoma patients (Japanese) |
Tsukasa Yonemoto |
Controlled-access (Type I) |
|
JGAS000288 |
Comprehensive genome analysis related to individual differences in phenotypic expression in autosomal dominant diseases caused by haploinsufficiency |
v1:2021/05/11 |
NGS (Target Capture, Target RNA-seq) |
Illumina (MiSeq) |
20 patients with neurofibromatosis type 1 (Japanese) |
Yo Niida |
Controlled-access (Type I) |
|
JGAS000285 JGAS000589 |
Analysis of the immune status of melanoma and other skin tumors |
v1:2021/12/20 v2:2022/02/07 v3:2024/11/13 |
NGS (Exome, RNA-seq, scRNA-seq, scTCR-seq, Target Capture) |
Illumina (HiSeq 2500) Thermo Fisher Scientific (Ion Torrent proton) |
melanoma: 4 + 9 cases (Japanese) |
Takashi Inozume |
Controlled-access (Type I) |
|
JGAS000300 |
A study of molecular pathology for carcinogenesis and progression of breast cancer |
v1:2021/08/27 |
NGS (Amplicon-seq) |
Thermo Fisher Scientific (Ion Proton) |
2 patients of lobular carcinoma in situ with ductal carcinoma in situ (Japanese) |
Shinobu Masuda |
Controlled-access (Type I) |
|
JGAS000294 |
Integrated analysis of selective mRNA export by mRNA export factors, UAP56 and URH49 |
v1:2022/04/22 |
NGS (RNA-seq) |
Illumina (NovaSeq 6000) |
HeLa cells with knockdown of the target genes: 20 samples (Cell-line) |
Kenichi Fujita |
Controlled-access (Type I) |
|
JGAS000313 |
Comprehensive analysis of genetic abnormalities in solid tumors |
v1:2021/08/16 |
NGS (Exome) |
Illumina (NovaSeq 6000) |
Nine subjects without Hp infection or gastric cancer (healthy population) (Japanese) |
Seishi Ogawa |
Controlled-access (Type I) |
|
JGAS000308 |
Development of a general-purpose genetic diagnostic panel for Gorlin syndrome and its application to liquid biopsy |
v1:2021/10/01 |
NGS (Target Capture) |
Illumina (MiSeq) |
12 patients with Gorlin syndrome 3 blood relatives (Japanese) |
Toshifumi Azuma |
Controlled-access (Type I) |
|
JGAS000303 JGAS000564 |
Analysis of genes related to the oncogenesis, progression or effectiveness of drug therapies of urological tumors |
v1:2022/09/09 v2:2023/04/18 v3:2023/05/10 |
NGS (scRNA-seq, Exome, RNA-seq, WGS) |
Illumina (NextSeq 500, HiSeq 2500, NovaSeq 6000/PE150) |
renal cell carcinoma: 15 + 30 cases sporadic oncocytoma: 7 cases (Japanese) |
Hisashi Hasumi |
Controlled-access (Type I) |
|
JGAS000304 JGAS000305 |
Analysis of genome of breast cancer stem cells |
v1:2022/07/07 |
NGS (Exome, scRNA-seq) |
Illumina (HiSeq 3000, NovaSeq 6000) |
Breast cancer: 5 cases (Japanese) |
Noriko Gotoh |
Controlled-access (Type I) |
|
JGAS000307 |
Stratification of refractory malignant lymphoma by genomic/epigenomic analysis and immunohistochemistry and development of novel therapeutic approaches |
v1:2022/09/05 |
NGS (Target Capture) |
Illumina (NextSeq 550) |
177 patients with diffuse large B-cell lymphoma (Japanese) |
Emiko Sakaida |
Controlled-access (Type I) |
|
DRA012560 |
The research for the identification of neoantigen and tumor immune microenvironment in lung cancer |
v1:2022/01/07 |
NGS (RNA-seq) |
Illumina (NovaSeq 6000) |
lung cancer: 113 cases (Japanese) |
Hirokazu Matsushita |
Unrestricted-access |
|
JGAS000309 |
Elucidation of the molecular mechanism that controls the transition from precancerous lesions to invasive cancer due to disruption of biological maintenance function |
v1:2023/01/19 |
NGS (scRNA-seq) |
Illumina (NovaSeq 6000) |
Breast cancer: 4 cases (Japanese) |
Jun Nakayama |
Controlled-access (Type I) |
|
JGAS000311 JGAS000523 |
Elucidation of molecular mechanism of NAFLD-HCC |
v1:2022/09/12 v2:2022/11/15 |
NGS (Visium Spatial Gene Expression, Target Capture) Histological image |
Illumina (NovaSeq 6000) Thermo Fisher Scientific (Ion Proton) |
55 hepatocellular carcinoma (Japanese) |
Takahiro Kodama (Genome Science) |
Controlled-access (Type I) |
|
JGAS000310 JGAS000573 JGAS000690 |
Genome sequence comparison of human iPS cell lines |
v1:2021/11/02 v2:2023/03/29 v3:2024/05/01 |
NGS (WGS) |
Illumina (HiSeq X) Nanopore (PromethION) |
5 +1 +1 Human iPS cell lines (Cell-line) |
Shihori Yokobayashi |
Controlled-access (Type I) |
|
JGAS000317 |
Mechanisms on relapse after allogeneic hematopoietic cell transplantation in CMML |
v1:2022/09/09 |
NGS (RNA-seq, Exome) Methylation array |
Illumina (NovaSeq 6000, MethylationEPIC) |
chronic myelomonocytic leukemia (CMML): 1 case (Japanese) |
Yu Akahoshi |
Controlled-access (Type I) |
|
JGAS000321 |
Comprehensive analysis of interaction between human gene expression and environmental metagenomes |
v1:2022/03/07 |
NGS (WGS, scRNA-seq, TCR-seq, BCR-seq, CyTOF) |
Illumina (NovaSeq 6000) 10x Genomics (Chromium Controller) |
7 healthy volunteers (Japanese) |
Yutaka Suzuki |
Controlled-access (Type I) |
|
JGAS000359 |
Elucidation of molecular mechanisms of tumorigenesis and development of diagnoses and treatments based on comprehensive genomic analyses in pancreatic tumors, duodenal tumors and biliary tumors |
v1:2021/12/10 v2:2023/09/08 |
NGS (WGS, Exome, RNA-seq) |
Illumina (HiSeq 2000/2500) |
Pancreatic tumor: 57+6 cases Duodenal tumor: 6+1 cases Biliary tumors: 11 cases (Japanese) |
Shinichi Yachida |
Controlled-access (Type I) |
|
JGAS000330 |
Development of blood-based biomarkers for precision medicine in castration-resistant prostate cancer |
v1:2021/09/24 |
NGS (Target Capture) |
Illumina (NovaSeq 6000) |
100 CRPC patients (Japanese) |
Shusuke Akamatsu |
Controlled-access (Type I) |
|
JGAS000320 |
Exploratory research of genetic factors that regulate the therapeutic sensitivity of hematopoietic malignancy |
v1:2022/07/25 |
NGS (WGS) |
Illumina (HiSeq X Ten) BGI (BGISEQ-500) |
ATL: 7 cases ATL cell line: 1 sample (Japanese) |
Takaomi Sanda |
Controlled-access (Type I) |
|
JGAS000708 |
Single cell analysis of tumor-infiltrating T cells |
v1:2024/05/29 |
NGS (Exome, RNA-seq) |
Illumina (HiSeq X) |
esophageal cancer: 28 cases (Japanese) |
Shogo Kumagai |
Controlled-access (Type I) |
|
JGAS000351 |
Search for biomarkers for diagnosis, evaluation of therapeutic effect, and follow-up of skin tumors (prospective observational study) |
v1:2024/10/25 |
NGS (Amplicon-seq) |
Thermo Fisher Scientific (Ion S5) |
melanoma: 98 cases sebaceous nevus: 1 case (Japanese) |
Hisashi Uhara (Genome Science) |
Controlled-access (Type I) |
|
JGAS000348 |
Comprehensive study of color vision diversity |
v1:2022/09/15 |
NGS (WGS) |
Illumina (NovaSeq 6000) Nanopore (PromethION) |
1 healthy donor |
Chihiro Hiramatsu |
Controlled-access (Type I) |
|
DRA012759 |
Analysis of chromosome background of cancerous mutations using a long read sequencer |
v1:2022/09/15 |
NGS (WGS) |
Nanopore (PromethION) |
Healthy white B-Lymphocyte cell line HG002 (NA24385): 1 sample (Cell-line) |
Yutaka Suzuki |
Unrestricted-access |
|
JGAS000367 |
Whole-genome and whole-exome analyses of cancer |
v1:2021/11/12 |
NGS (Exome, RNA-seq) |
Illumina (HiSeq 2000/2500) |
89 Esophageal squamous cell carcinomas (Japanese) |
Johji Inazawa |
Controlled-access (Type I) |
|
JGAS000368 |
An integrative analysis study of genomic abnormalities and immune status in breast cancer patients and high-risk individuals (Immuno-Genome Atlas Project) |
v1:2021/11/29 |
NGS (Target Capture) |
Illumina (HiSeq 2500, NovaSeq 6000) MGI (DNBSEQ-G400) |
26 patients with breast cancer (Japanese) |
Hiroyuki Mano |
Controlled-access (Type I) |
|
JGAS000382 JGAS000683 |
iPS Cell Advanced Characterization and Development of modified iPS cells |
v1:2022/09/05 v2:2024/03/18 |
NGS (RNA-seq) |
Illumina (NovaSeq 6000) |
iPS cells derived from patients with Wilson's disease: 6 samples iPS cells derived from patients with juvenile nephron tabes (NPH1): 12 samples iPS cells derived from healthy donors: 6+6 samples (Cell-line) |
Yohei Hayashi |
Controlled-access (Type I) |
|
JGAS000370 |
Exome sequencing of human breast cancer tissues resistant to taxanes. |
v1:2022/04/08 |
NGS (Exome) |
Illumina (HiSeq 2000/2500) |
6 breast cancers (Japanese) |
Yumi Wanifuchi-Endo |
Controlled-access (Type I) |
|
JGAS000377 |
A multicenter study of biological and genetic manifestations of subsequent solid cancers after hematopoietic cell transplantation |
v1:2021/11/29 |
NGS (Exome) |
Illumina (NovaSeq 6000) MGI (DNBSEQ-G400) |
14 de novo cancer patients (Japanese) |
Yoshihiro Inamoto |
Controlled-access (Type I) |
|
JGAS000361 |
Cancer Genome Sequencing Analysis |
v1:2021/10/15 |
NGS (WGS) |
Nanopore (MinION) |
9 liver cancers (Japanese) |
Hidewaki Nakagawa |
Controlled-access (Type I) |
|
JGAS000416 |
Analysis for skin molecules in patients with atopic dermatitis No.2. |
v1:2022/03/11 |
NGS (RNA-seq) |
Thermo Fisher Scientific (Ion S5) |
29 healthy male subjects atopic dermatitis: 30 cases (Japanese) |
Takayoshi Inoue |
Controlled-access (Type I) |
|
JGAS000417 |
Circadian rhythm of skin molecules. |
v1:2022/03/11 |
NGS (RNA-seq) |
Thermo Fisher Scientific (Ion S5) |
10 healthy female subjects (Japanese) |
Takayoshi Inoue |
Controlled-access (Type I) |
|
JGAS000418 |
Comparison between sebum and stratum corneum molecules. |
v1:2022/03/11 |
NGS (RNA-seq) |
Thermo Fisher Scientific (Ion S5) |
10 healthy male subjects (Japanese) |
Takayoshi Inoue |
Controlled-access (Type I) |
|
JGAS000412 JGAS000541 JGAS000561 |
Management of Biobank Japan and the investigation of disease biomarkers for the realization of personalized medicine Discovery of disease makers from disease cohort network |
v1:2021/11/30 v2:2022/07/28 v3:2022/09/08 v4:2023/04/24 v5:2023/07/27 v6:2024/05/22 |
SNP-chip Metabolome |
Illumina (Asian Screening Array, HumanOmniExpressExome, HumanOmniExpress, HumanExome) Bruker (AVANCE IIIHD) |
11,716 + 180,882 + 1,285 + 2,570 + 40,907 patients from BBJ 1st cohort 42,689 patients from BBJ 2nd cohort ToMMo: 49,621 individuals UK biobank: 456,327 individuals FinnGen: 230,635 individuals (Japanese, British, Finnish) |
Koichi Matsuda |
Controlled-access (Type I) |
|
DRA016285 DRA016393 DRA016394 DRA016395 DRA018714 |
Genetic study of complex diseases through comprehensive analysis of functional variants |
v1:2024/06/17 v2:2024/06/20 |
NGS (RNA-seq, Iso-seq) |
Illumina (NovaSeq 6000) Nanopore (MinION) PacBio (Sequel II/IIe) |
immortalized B cell lines from healthy Japanese volunteers: 95 samples (Cell-line) 1 healthy subject (Japanese) |
Yuta Kochi |
Unrestricted-access |
|
JGAS000383 |
Analysis of the relationship between disease phenotype and genotype in patients with Alzheimer's disease |
v1:2021/11/19 |
SNP-chip |
Illumina (Infinium OmniExpressExome-8) |
102 patients with sporadic Alzheimer's disease (Japanese) |
Haruhisa Inoue |
Controlled-access (Type I) |
|
JGAS000385 |
Comprehensive analysis of genetic alterations in hematological malignancies |
v1:2022/01/14 v2:2022/07/28 |
NGS (Exome, RNA-seq, scRNA-seq, ChIP-seq, Target Capture) Methylation array |
Illumina (HiSeq 2500/X Ten, MethylationEPIC, HumanMethylation450) |
84 infants with KMT2A-rearranged acute lymphoblastic leukemia 3 cell lines derived from infants with KMT2A-rearranged acute lymphoblastic leukemia (Japanese) |
Junko Takita |
Controlled-access (Type I) |
|
JGAS000535 |
Whole-genome sequencing of esophageal cancer to elucidate pathogenesis and search for treatment-sensitive markers |
v1:2022/05/26 |
NGS (WGS, RNA-seq) |
Illumina (HiSeq 2000/2500) |
Esophageal squamous cell carcinoma: 110 cases |
Hidewaki Nakagawa |
Controlled-access (Type I) |
|
JGAS000413 JGAS000707 |
Research on the establishment of patient derived xenograft models useful for drug discovery research |
v1:2021/12/06 v2:2024/06/20 |
NGS (Exome, RNA-seq) |
Illumina (NovaSeq 6000) |
Non-small cell lung cancer: 4 cases Cancer: 52 cases (Japanese) |
Akinobu Hamada |
Controlled-access (Type I) |
|
JGAS000483 |
Clinical sequence of hematological malignancy |
v1:2022/03/09 |
NGS (Target Capture) |
Illumina (MiSeq) |
B-ALL: 1 case (Japanese) |
Arinobu Tojo |
Controlled-access (Type I) |
|
JGAS000487 |
Development of diagnostic markers for prostate cancer using genetic polymorphisms Identification of Rare Variants Involved in the Development of Prostate Cancer in Japanese |
v1:2022/01/21 |
NGS (Target Capture) |
Illumina (HiSeq 2500) |
1,336 men with suspected prostate cancer scheduled for prostate biopsy (Japanese) |
Shusuke Akamatsu |
Controlled-access (Type I) |
|
JGAS000480 |
Immunomonitoring study in patients with malignant tumors |
v1:2022/01/25 |
NGS (scRNA-seq, TCR-seq) |
MGI (DNBSEQ-G400) |
lung adenocarcinoma: 2 cases head and neck cancer: 3 cases (Japanese) |
Yosuke Togashi |
Controlled-access (Type I) |
|
JGAS000482 |
Comprehensive analysis of interaction between human gene expression and environmental metagenomes |
v1:2022/06/17 |
NGS (scRNA-seq) |
Illumina (NovaSeq 6000) |
Myasthenia gravis: 4 cases (Japanese) |
Tatsusada Okuno |
Controlled-access (Type I) |
|
JGAS000489 |
Biomarker exploration of colon cancer |
v1:2022/01/24 |
NGS (CAGE-seq) |
Illumina (HiSeq 2500) |
45 colon cancers (Japanese) |
Yasushi Kogo |
Controlled-access (Type I) |
|
JGAS000515 |
Genetic analysis of cerebrovascular diseases and neuromuscular disorders |
v1:2022/04/11 |
NGS (WGBS) |
Illumina (NovaSeq 6000) |
10 neuromyelitis optica (NMOSD) positive for AQP4 antibody 8 healthy controls (Japanese) |
Tatsusada Okuno |
Controlled-access (Type I) |
|
JGAS000507 |
Screening of neoantigens and neoantigen reactive T cell receptors in hepatobiliary and pancreatic cancer for clinical application of personalized T cell therapy |
v1:2022/02/25 |
NGS (Exome, RNA-seq) |
Illumina (NextSeq 550) |
hepatocellular carcinoma: 28 cases metastatic colorectal carcinoma: 18 cases (Japanese) |
Toshihiro Suzuki |
Controlled-access (Type I) |
|
JGAS000509 |
Frequency of germline variants in genes associated with DNA repair among adanced prostate cancer patients in Japan |
v1:2023/05/11 |
NGS (Target Capture) |
Illumina (HiSeq 2500) |
prostate cancer: 129 cases (Japanese) |
Shusuke Akamatsu |
Controlled-access (Type I) |
|
JGAS000522 |
Next-generation sequencing-based comprehensive genetic analysis of undiagnosed disease |
v1:2022/06/17 |
NGS (Exome) |
Illumina (HiSeq 2500) |
Patients with undiagnosed diseases and their parents: 177 families（522 samples） (Japanese) |
Hideki Muramatsu |
Controlled-access (Type I) |
|
Construction of control data for the promotion of genomic medicine for cancers and rare diseases |
v1:2023/02/01 |
NGS (WGS) |
Illumina (NovaSeq 6000) |
9290 healthy individuals (Japanese) |
Katsushi Tokunaga |
Unrestricted-access |
|
|
JGAS000510 |
A study on personalized medicine in genitourinary cancers using genetic biomarkers. |
v1:2022/05/30 |
NGS (Exome) |
Illumina (NovaSeq 6000) |
1 castration-resistant prostate cancer (Japanese) |
Shusuke Akamatsu |
Controlled-access (Type I) |
|
DRA014819 |
Research on new diagnosis and clinical picture of lymphoproliferative diseases by combining genetic analysis and immunological traits |
v1:2022/09/14 |
NGS (Target Capture) |
Illumina (NextSeq 500) |
Waldenström macroglobulinemia: 10 cases non IgM-type lymphoplasmacytic lymphoma: 10 cases (Japanese) |
Akihiko Yokohama |
Unrestricted-access |
|
JGAS000521 |
Fundamental research on establishment of a novel tailor-maid therapy for refractory gynecologic malignancy based on comprehensive omics analysis |
v1:2024/07/19 |
NGS (scRNA-seq) |
Illumina (NovaSeq 6000) |
squamous cell carcinoma arising from mature teratoma of the ovary: 5 cases (Japanese) |
Kosuke Yoshida |
Controlled-access (Type I) |
|
JGAS000575 |
Comprehensive cancer genome, epigenome, and immunogenome analysis for gastric cancer unaffected by aging or Helicobacter pylori infection |
v1:2022/11/22 |
NGS (Exome) |
Illumina (HiSeq 2000) |
H. Pylori uninfected gastric cancer: 27 cases H. Pylori infected gastric cancer: 36 cases (Japanese) |
Seiichi Mori |
Controlled-access (Type I) |
|
JGAS000520 |
Comprehensive genomic analysis using next-generation sequencer for pediatric solid tumor cases |
v1:2022/08/04 |
NGS (WGS, Target Capture) |
Illumina (Hiseq X Ten) |
Colorectal cancer: 24 cases Retinoblastoma: 1 case Glioblastoma: 2 cases |
Utako Oba |
Controlled-access (Type I) |
|
JGAS000538 |
Immunohistochemical and molecular pathological search in gastrointestinal tumors |
v1:2022/06/27 |
NGS (Exome) |
Illumina (NovaSeq 6000) |
Colorectal cancer: 29 cases (Japanese) |
Shigeki Sekine |
Controlled-access (Type I) |
|
E-GEAD-759 JGAS000739 |
Development of COVID19 vaccine and evaluation system based on genetics of COVID-19 |
v1:2022/05/26 v2:2022/06/14 v3:2024/06/24 v4:2024/10/02 |
NGS (RNA-seq) SNP-chip Protein expression eQTL/sQTL/pQTL Presence or absence of endogenous herpesvirus 6, anellovirus load |
Illumina (Asian Screening Array, NovaSeq6000) Olink (Olink Explore 3072) |
COVID-19: 2,393 cases Healthy controls: 3,289 individuals (Japanese) |
Koichi Fukunaga |
Unrestricted-access Controlled-access (Type I) |
|
JGAS000533 JGAS000611 |
Genome sequencing analysis for biliary tract cancer |
v1:2022/08/04 v2:2023/05/16 |
NGS (WGS, RNA-seq, Amplicon-seq) |
Illumina (HiSeq 2500) MGI (MGISEQ-2000RS) |
kidney cancers: 38 cases chronic kidney disease: 77 cases (Japanese) HEK293 cell line: 1 sample (Cell-line) |
Hidewaki Nakagawa |
Controlled-access (Type I) |
|
JGAS000528 JGAS000551 |
Fundamental study for regenerative medicine utilizing cord blood |
v1:2022/08/05 |
NGS (scRNA-seq, ATAC-seq) |
Illumina (NovaSeq 6000) |
30 healthy volunteers |
Kohshi Ohishi (Genome Science) |
Controlled-access (Type I) |
|
Comprehensive genetic analysis of acute encephalopathy |
v1:2022/05/23 v2:2022/07/15 |
Sanger-seq SNP-chip |
Life Technologies (310 Genetic Analyzer, 3100 Genetic Analyzer, 3130xl Genetic Analyzer) Affymetrix (Japonica Array v2) |
Acute encephalopathy with biphasic seizures and late reduced diffusion (AESD): 283 cases Healthy controls: 799 individuals (Japanese) |
Masashi Mizuguchi |
Unrestricted-access |
|
|
JGAS000537 |
Analysis of ATL progression by CD30 signaling and its biomarkers |
v1:2023/05/15 |
NGS (Exome) Array CGH |
Illumina (NovaSeq 6000) Agilent Technologies (GenetiSure Cancer Research CGH+SNP Microarray 2 x 400K) |
ATL: 8 cases (Japanese) |
Makoto Nakashima |
Controlled-access (Type I) |
|
JGAS000689 DRA018405 E-GEAD-739 E-GEAD-740 E-GEAD-741 E-GEAD-742 E-GEAD-743 E-GEAD-744 E-GEAD-745 E-GEAD-746 |
Comprehensive analysis of genetic alterations in hematological malignancies |
v1:2024/06/13 |
NGS (5' single-cell RNA-seq, 3' single-cell RNA-seq, Micro-C and Region Capture Micro-C, CITE-seq, Multimodal assay including single-nucleus ATAC-seq, 3' and 5’ single-nucleus RNA-seq, and 5' single-cell RNA-seq, MAS-seq, CAGE-seq, and NET-CAGE-seq) |
Illumina (NovaSeq 6000, NextSeq 500) PacBio (Sequel Ⅱ) |
3 healthy individuals (1 male, 2 females) (Japanese) CRISPR-activated Jurkat cells: 15 samples (Cell-line) |
Kazuhiko Yamamoto |
Unrestricted-access Controlled-access (Type I) |
|
JGAS000540 |
Analytical study of protein function and RNA expression involved in predicting treatment efficacy and adverse event development in lung cancer radiotherapy |
v1:2022/09/08 |
Metagenome |
Illumina (MiSeq) |
moyamoya disease: 27 cases non-moyamoya intracranial large artery disease: 7 cases controls: 15 individuals. (Japanese) |
Yohei Mineharu |
Controlled-access (Type I) |
|
JGAS000545 |
Analytical study of protein function and RNA expression involved in predicting treatment efficacy and adverse event development in lung cancer radiotherapy |
v1:2022/09/20 |
NGS (RNA-seq) |
Illumina (NovaSeq 6000) |
primary lung cancer: 5 cases (Japanese) |
Masanori Someya |
Controlled-access (Type I) |
|
Analyses of circulating tumor cells from patients with advanced urogenital cancer |
v1:2022/06/30 v2:2023/04/18 |
qRT-PCR |
BioRad (T100 Thermal cycler) |
127 patients with advanced metastatic castration-resistant prostate cancer (Japanese) |
Masayoshi Nagata |
Unrestricted-access |
|
|
JGAS000544 |
Genomic analysis of genitourinary tumors by next generation sequencing |
v1:2023/06/19 |
NGS (WGS, Exome, RNA-seq) Microarray |
Illumina (NovaSeq 6000, NextSeq 500, HiSeq X Ten) NanoString Technologies (nCounter Digital Analyzer) |
hereditary clear cell renal cell carcinoma associated with VHL disease: 10 cases (Japanese) |
Keisuke Kataoka |
Controlled-access (Type I) |
|
DRA015288 E-GEAD-579 DRA016520 E-GEAD-619 |
Molecular genetic and molecular epidemiological studies to improve the treatment of pancreatic cancer |
v1:2022/12/20 v2:2024/05/31 |
NGS (Visium Spatial Gene Expression) Histological image |
Illumina (NovaSeq 6000) |
1 + 2 colorectal cancers (Japanese) |
Koshi Mimori |
Unrestricted-access |
|
JGAS000557 JGAS000609 JGAS000610 |
Research for biological features by gene expression analysis and biomarkers at diagnosis/therapeutics in lung cancer |
v1:2022/11/30 v2:2023/01/11 v3:2023/02/15 v4:2023/08/09 v5:2024/06/05 |
NGS (WGS, Exome, RNA-seq, ATAC-seq) Methylation array |
Illumina (HiSeq 2000/X Ten, NovaSeq 6000, MethylationEPIC) |
lung cancer: 105 cases (Japanese) |
Hiroyuki Yasuda |
Controlled-access (Type I) |
|
JGAS000582 JGAS000586 JGAS000640 |
Research of genetic abnormalities related to the development and prognosis of adenocarcinoma and squamous cell carcinoma of the cervix and vaginal and vulvar cancer |
v1:2022/12/20 v2:2023/10/19 |
NGS (Exome, RNA-seq, scRNA-seq) |
Illumina (NovaSeq 6000, MiSeq) |
cervical cancer: 19 + 4 cases (Japanese) NIKS18 cell line: 5 samples (Cell-line) |
Kenbun Sone |
Controlled-access (Type I) |
|
JGAS000548 |
Genomic and Epigenetic Analysis on T/NK-cell lymphoma |
v1:2022/08/01 |
NGS (Target Capture) |
Illumina (NovaSeq 6000) |
Extranodal NK/T-cell lymphoma, nasal type: 67 cases (Japanese) |
Naoki Oishi |
Controlled-access (Type I) |
|
JGAS000546 |
Exploratory research on COVID-19 pathogenesis and aggravation |
v1:2022/12/21 |
NGS (scRNA-seq, scVDJ-seq) |
Illumina (NovaSeq 6000) |
COVID-19: 6 cases (Japanese) |
Ai Tachikawa |
Controlled-access (Type I) |
|
Comprehensive analysis of microsatellite polymorphisms in human populations |
v1:2022/08/29 |
NGS (WGS) |
Illumina (bam files were publicly available) |
Simons Genome Diversity Project (SGDP): 276 samples Human Genome Diversity Project (HGDP): 693 samples Jomon Individual: 1 individual |
Akihiro Fujimoto |
Unrestricted-access |
|
|
JGAS000569 |
The role of gut microbiota in metabolic diseases |
v1:2023/06/09 |
NGS (CAGE-seq) |
Illumina (HiSeq 2500) |
normoglycemic lean group: 103 individuals obese group: 98 cases prediabetic group: 97 cases (Japanese) |
Hiroshi Ohno |
Controlled-access (Type I) |
|
E-GEAD-511 E-GEAD-512 |
Pathogenesis of severe acute respiratory syndrome coronavirus 2 infection (COVID-19) |
v1:2023/03/16 |
NGS (scRNA-seq, RNA-seq, ATAC-seq) |
Illumina (NovaSeq 6000) |
COVID-19: 16 cases 10 healthy individuals (Japanese) |
Yasuhiro Kato |
Unrestricted-access |
|
JGAS000558 |
Clinical sequence of hematological malignancy |
v1:2022/09/21 |
NGS (Target Capture) |
Illumina (MiSeq) |
langerhans cell histiocytosis: 1 case (Japanese) |
Arinobu Tojo |
Controlled-access (Type I) |
|
JGAS000559 |
Identification and functional analysis of novel causative genes of ICF syndrome by whole genome sequencing |
v1:2022/11/29 |
NGS (PBAT-seq) |
Illumina (NovaSeq 6000) |
ICF syndrome: 1 case (Japanese) |
Motoko Unoki |
Controlled-access (Type I) |
|
JGAS000562 |
A study of resistance to novel coronavirus infection in health care workers |
v1:2022/09/28 |
NGS (Target Capture) |
Illumina (NextSeq 500) |
139 healthy persons (Japanese) |
Atsushi Kawaguchi |
Controlled-access (Type I) |
|
JGAS000574 |
Research on genes and proteins associated with liver disease. |
v1:2022/12/22 |
Metagenome |
Illumina (MiSeq) |
NASH: 20 cases (Japanese) |
Ryosuke Tateishi |
Controlled-access (Type I) |
|
JGAS000572 MTBKS213 MTBKS214 |
Elucidation of disease state by multi-layered omics analysis
|
v1:2022/11/22 |
Metabolome |
Agilent Technologies (Agilent CE system, Agilent LC System) |
type2 diabetes: 300 cases (Japanese) |
Toshimasa Yamauchi |
Unrestricted-access Controlled-access (Type I) |
|
JGAS000585 |
Establishment of xenografts and cultured cell lines from clinical samples. |
v1:2022/12/27 v2:2023/03/28 |
NGS (Target Capture) |
Illumina (NextSeq 500) |
endometrial cancer: 2 + 4 cases (Japanese) |
Toshio Imai |
Controlled-access (Type I) |
|
JGAS000579 |
Research on the genetic basis of arrhythmia syndrome |
v1:2022/12/13 |
NGS (Amplicon-seq) |
Thermo Fisher Scientific (Ion Proton) |
LQTS: 556 cases (Japanese) |
Toshihiro Tanaka |
Controlled-access (Type I) |
|
JGAS000583 JGAS000612 |
Basic research to elucidate the pathogenesis of hemolytic anemia |
v1:2024/09/09 |
NGS (Exome) |
Illumina (NovaSeq 6000) |
Cold agglutinin disease: 2 cases (Japanese) |
Daisuke Koyama |
Controlled-access (Type I) |
|
JGAS000578 |
Immune regulation by cotrolling regulatory T cell-specific epigenome |
v1:2023/11/20 |
NGS (scRNA-seq, scVDJ-seq) |
Illumina (NovaSeq 6000) |
myasthenia gravis: 2 cases multiple sclerosis: 4 cases systemic lupus erythematosus: 3 cases 3 healthy cases (Japanese) |
Shimon Sakaguchi |
Controlled-access (Type I) |
|
JGAS000588 |
A biomarker study of a multicenter Phase II Trial of Nivolumab for Unresectable or Recurrent Thymic Carcinoma (NCCH1505) |
v1:2023/01/05 |
NGS (Target Capture) |
Illumina (NextSeq 500) |
thymic carcinoma: 2 cases (Japanese) |
Hidehito Horinouchi |
Controlled-access (Type I) |
|
JGAS000587 |
Analysis of genetic and epigenetic abnormalities in hematopoietic diseases |
v1:2023/01/19 |
NGS (WGS) |
Illumina (NovaSeq 6000) |
AML with FUS-ERG: 1 case (Japanese) |
Masahiro Kawahara |
Controlled-access (Type I) |
|
JGAS000602 |
Analysis of the effect of abatacept for the transcriptome of multiple lymphoid subsets |
v1:2023/03/28 |
NGS (RNA-seq) |
Illumina (NovaSeq 6000) |
Rheumatoid arthritis: 5 cases (Japanese) |
Keishi Fujio |
Controlled-access (Type I) |
|
JGAS000603 JGAS000718 |
Deciphering molecular mechanisms underlying hematological malignancies and development of novel therapeutic approaches |
v1:2024/06/19 |
NGS (RNA-seq, Target Capture, ATAC-seq) |
Illumina (HiSeq 1500/2500, MiSeq) |
AML: 4 cases MDS: 30 cases (Japanese) normal cell: 6 samples (Cell-line) |
Atsushi Iwama |
Controlled-access (Type I) |
|
JGAS000597 JGAS000599 |
Comprehensive genetic analysis of Combined hepatocellular-cholangiocarcinoma, Cholangiolocarcinoma, Keratin 19-expressing hepatocellular carcinoma, and SOX9-expressing hepatocellular carcinoma |
v1:2023/12/14 v2:2024/01/09 |
NGS (Exome) |
Illumina (NovaSeq 6000) |
Cholangiolocarcinoma: 8 cases Combined hepatocellular-cholangiocarcinoma: 13 cases (Japanese) |
Takamichi Ishii |
Controlled-access (Type I) |
|
DRA015813 |
Localized assembly for long reads enables genome-wide analysis of repetitive regions at single-base resolution in human genomes |
v1:2023/04/11 |
NGS (WGS) |
Nanopore (MinION) |
HapMap: 1 sample (Cell-line) |
Akihiro Fujimoto |
Unrestricted-access |
|
JGAS000605 |
Genetic analysis of fetal developmental abnormalities |
v1:2023/04/04 |
NGS (Capture Methyl-seq) |
Illumina (HiSeq X) |
4 healthy women (Japanese) |
Kazuhiko Nakabayashi |
Controlled-access (Type I) |
|
JGAS000621 |
Elucidation of genetic factors associated with chronic endometritis (CE) through genomic and epigenomic analyses, and investigation on novel diagnostic and therapeutic methods for CE |
v1:2023/06/30 |
NGS (RNA-seq) |
Illumina (HiSeq X Ten) |
chronic endometritis: 24 cases 33 controls (Japanese) |
Keiji Kuroda |
Controlled-access (Type I) |
|
JGAS000606 |
Establishment of a human tongue cancer organoid biobank |
v1:2024/09/25 |
NGS (scRNA-seq, scATAC-seq) |
Illumina (NovaSeq 6000) |
Tongue cancer: 4 cases (Japanese) |
Taku Sato (Genome Science) |
Controlled-access (Type I) |
|
JGAS000693 |
To explore new biomarkers or therapeutic target molecules using samples with patients with autoimmune diseases |
v1:2024/08/23 |
NGS (RNA-seq) |
Illumina (NextSeq 500) |
treatment-naïve rheumatoid arthritis: 6 cases 6 healthy individuals (Japanese) |
Hiroto Tsuboi |
Controlled-access (Type I) |
|
JGAS000613 JGAS000757 |
Multi‐institutional joint research of spatial transcriptome analysis for non-small cell lung cancers |
v1:2024/04/08 v2:2024/11/20 |
NGS (Visium Spatial Gene Expression, WGS, t-nanoEM) Histological image Xenium In Situ Gene Expression Multiplex Fluorescence Immunostaining |
Illumina (NovaSeq 6000) 10x Genomics (Xenium Analyzer) Akoya Biosciences (PhenoCycler) Nanopore (PromethION) |
8 non-small cell lung cancer patients (Japanese) |
Ayako Suzuki |
Controlled-access (Type I) |
|
JGAS000678 |
Comprehensive survey for the construction of an integrated database of food, gut microbiome, and health information (the "Sukoyaka Health Survey"): Hokkaido Information University An epidemiological study examining the relationship among food, health, and genome: Hokkaido Information University |
v1:2024/04/01 |
Attributes, Blood and Urine Test Body measurement Questionnaire, Interview Sleep diary, Heart rate/brain wave during sleep Microbiome composition Nutrient intake, Food frequency questionnaire Metabolomics SNP-chip |
Affymetrix (Japonica Array v2) |
963 healthy individuals (Japanese) |
Jun Nishihira |
Controlled-access (Type I) |
|
JGAS000679 |
Comprehensive survey for the construction of an integrated database of food, gut microbiome, and health information (the "Sukoyaka Health Survey"): University of Miyazaki An epidemiological study examining the relationship among food, health, and genome: University of Miyazaki |
v1:2024/04/01 |
Attributes, Blood and Urine Test Body measurement Questionnaire, Interview Sleep diary, Heart rate/brain wave during sleep Microbiome composition Nutrient intake, Food frequency questionnaire Metabolomics SNP-chip |
Affymetrix (Japonica Array v2) |
50 healthy individuals (Japanese) |
Manabu Yoshimura |
Controlled-access (Type I) |
|
JGAS000680 |
Comprehensive survey for the construction of an integrated database of food, gut microbiome, and health information (the "Sukoyaka Health Survey"): Kyoto University An epidemiological study examining the relationship among food, health, and genome: Kyoto University |
v1:2024/04/01 |
Attributes, Blood and Urine Test Body measurement Questionnaire, Interview Sleep diary, Heart rate/brain wave during sleep Microbiome composition Nutrient intake, Food frequency questionnaire SNP-chip |
Affymetrix (Japonica Array v2) |
50 healthy individuals (Japanese) |
Nobuya Inagaki |
Controlled-access (Type I) |
|
JGAS000681 |
Comprehensive survey for the construction of an integrated database of food, gut microbiome, and health information (the "Sukoyaka Health Survey"): University of Nagasaki |
v1:2024/04/01 |
Attributes, Blood and Urine Test Body measurement Questionnaire, Interview Sleep diary, Heart rate/brain wave during sleep Microbiome composition Nutrient intake, Food frequency questionnaire |
- |
59 healthy individuals (Japanese) |
Kazunari Tanaka |
Controlled-access (Type I) |
|
JGAS000616 |
Exploratory studies of molecular biological mechanisms related to the breast cancer microenvironment |
v1:2024/06/12 |
NGS (Visium Spatial Gene Expression) Histological image |
Illumina (NovaSeq 6000) |
breast cancer: 2 cases (Japanese) |
Shinpei Kawaoka (Genome Science) |
Controlled-access (Type I) |
|
JGAS000618 |
Development of cell lines and mouse models of bone and soft tissue sarcoma to establish novel treatment |
v1:2023/06/29 |
NGS (Exome, RNA-seq) |
Illumina (NovaSeq 6000) MGI (DNBSEQ-G400) |
giant cell tumor of bone: 1 case (Japanese) |
Toru Wakamatsu |
Controlled-access (Type I) |
|
DRA016537 E-GEAD-622 |
Elucidation of the mechanisms that give rise to driver mutations in colorectal carcinogenesis |
v1:2024/04/12 |
NGS (Visium Spatial Gene Expression) Histological image |
MGI (DNBSEQ-G400) |
colorectal cancer: 4 cases (Japanese) |
Koshi Mimori |
Unrestricted-access |
|
JGAS000622 |
Investigation of the utility of liquid biopsy in urologic cancer |
v1:2023/07/27 |
NGS (Target Capture) |
Illumina (NextSeq 500) |
Metastatic urothelial carcinoma: 16 cases (Japanese) |
Kazuki Hamada |
Controlled-access (Type I) |
|
JGAS000623 |
Research on the identification of cancer stem cells for peidatric and adult malignancies |
v1:2023/12/25 |
NGS (Exome, RNA-seq, small RNA-seq) |
Illumina (HiSeq X, NextSeq 550) MGI (DNBSEQ-G400RS) |
Pediatric B-cell precursor acute lymphocytic leukemia: 69 cases (Japanese) |
Junko Takita |
Controlled-access (Type I) |
|
JGAS000617 E-GEAD-623 |
The Generation of Human Disease-Specific iPS Cells and the Use of Such iPS Cells for Disease Analysis |
v1:2023/08/29 |
NGS (RNA-seq) |
Illumina (NextSeq 2000) |
Familial interstitial pneumonia with SFTPC variant: 1 case (Japanese) |
Shimpei Gotoh |
Unrestricted-access Controlled-access (Type I) |
|
JGAS000619 |
Analysis of genes that confer exceptional response in anticancer therapy |
v1:2023/06/27 |
NGS (Exome, RNA-seq, Target Capture) |
Illumina (NextSeq 550, NovaSeq 6000) |
Intimal sarcoma with MDM2 amplification: 11 cases (Japanese) |
Takafumi Koyama |
Controlled-access (Type I) |
|
JGAS000625 |
Investigation of molecular diagnosis by molecular biological analysis using next-generation sequencer for actionable endocrine diseases (including neoplastic diseases) |
v1:2023/07/18 |
NGS (Exome) |
Illumina (HiSeq 2500) |
FBPase deficiency: 1 case 3 family members (Japanese) |
Tomoaki Tanaka |
Controlled-access (Type I) |
|
JGAS000628 |
Comprehensive analysis on medical and omics data from patients with atopic dermatitis |
v1:2023/07/20 |
NGS (RNA-seq) |
Illumina (HiSeq 1500/2500) |
Atopic dermatitis: 161 cases 41 healthy controls (Japanese) |
Haruhiko Koseki |
Controlled-access (Type I) |
|
DRA016800 |
Elucidation of molecular mechanisms of lung cancer development and progression based on genome analysis |
v1:2023/07/25 |
NGS (WGS) |
Illumina (NovaSeq 6000) |
SAEC and its derived cell lines: 5 samples (Cell-line) |
Bunsyo Shiotani |
Unrestricted-access |
|
E-GEAD-635 DRA019233 E-GEAD-867 DRA019274 E-GEAD-872 |
Elucidation of biological responses in intractable immune disorders and cancer and development of novel therapies through sequential multilevel omics analysis. |
v1:2023/08/10 v2:2024/09/27 v3:2024/10/16 |
NGS (CITE-seq, BD Ab-seq) |
Illumina (HiSeq 2500, NovaSeq 6000) |
microscopic polyangiitis: 10 cases systemic sclerosis: 21 cases 10 healthy donors (Japanese) |
Takehisa Kitazawa |
Unrestricted-access |
|
JGAS000641 JGAS000653 JGAS000664 |
Application of organoid culture system of human gastrointestinal and thoracic cancer in genome medicine |
v1:2024/04/24 v2:2024/05/08 v3:2024/06/17 |
NGS (Exome, RNA-seq) |
Illumina (NovaSeq 6000) |
pulmonary large cell neuroendocrine carcinoma: 3 cases mucus-producing solid-dominant adenocarcinoma of lung: 1 case pulmonary adenocarcinoma harboring EML4-ALK variant 3: 1 case (Japanese) |
Takuya Fukazawa |
Controlled-access (Type I) |
|
JGAS000636 |
Comprehensive elucidation of inflammatory muscle diseases by multi-omics analysis |
v1:2024/10/23 |
NGS (RNA-seq) |
MGI (DNBSEQ) Nanopore (PromethION) |
sarcoid myopathy: 22 cases (Japanese) |
Aritoshi Iida |
Controlled-access (Type I) |
|
JGAS000654 |
Diagnosis and Research on Familial, Young-onset and Hereditary Cancers |
v1:2024/08/01 |
NGS (WGS) |
Nanopore (GridION) |
hereditary cancer syndromes: 33cases (Japanese) |
Yuichi Shiraishi |
Controlled-access (Type I) |
|
JGAS000645 |
Establishment of cell lines derived from head and neck malignancies Comprehensive genetic analysis and database construction for head and neck malignancies |
v1:2023/11/02 |
NGS (Exome) |
MGI (DNBSEQ-G400) |
external auditory canal squamous cell carcinoma: 1 case (Japanese) |
Takashi Nakagawa |
Controlled-access (Type I) |
|
JGAS000643 |
CRISPR screening identifies mechanisms of resistance to KRASG12C and SHP2 inhibitor combinations in non-small cell lung cancer |
v1:2023/11/13 |
NGS (WGS, RNA-seq) |
Illumina (NovaSeq 6000) |
tumor tissue collected from LU99 tumor-bearing mice: total 16 samples (Cell-line) |
Saskia Brachmann |
Controlled-access (Type I) |
|
JGAS000651 |
Genetic analysis aimed at elucidating the pathophysiology, vulnerability to onset, treatment responsiveness of neuropsychiatric disorders, and developing new treatments and diagnostic and preventive methods |
v1:2024/01/25 |
NGS (RNA-seq) |
Illumina (NovaSeq 6000) |
human iPS cells introduced single variants identified in patients with ASD: 5 samples control human iPS cells: 4 samples (Cell-line) |
Atsushi Takata |
Controlled-access (Type I) |
|
JGAS000659 JGAS000660 JGAS000667 E-GEAD-665 E-GEAD-667 |
Derivation of human trophoblast stem cells and analysis of those characteristics Derivation of human trophoblast stem cells and those epigenomic landscape |
v1:2024/09/25 |
NGS (RNA-seq, ChIP-seq, Hi-C, small RNA-seq, CUT&TAG-seq, Methyl-seq) |
Illumina (NovaSeq 6000, HiSeq 2500) |
placenta after artificial abortion: 1 sample discarded blastocyst: 1 sample hypertensive disorders of pregnancy: 14 cases normal pregnancy: 12 subjects (Japanese) |
Eri H Kobayashi |
Unrestricted-access Controlled-access (Type I) |
|
JGAS000665 |
Investigation of a method for generating cells for regenerative medicine using comprehensive nucleic acid analysis of iPS cell-derived cardiomyocytes |
v1:2024/03/18 |
NGS (scRNA-seq) |
Illumina (HiSeq 3000) |
Cardiomyocytes differentiated from human iPS cells established from healthy donor cells: 1 samples (Cell-line) |
Shigeru Miyagawa |
Controlled-access (Type I) |
|
JGAS000668 |
Genetic polymorphism and gene transcriptome study on the etiology of autism |
v1:2024/02/06 |
NGS (RNA-seq) |
Illumina (HiSeq 2000) |
Autistic disorder: 16 cases 17 Controls (Cell-line) |
Tetsuya Marui |
Controlled-access (Type I) |
|
JGAS000671 |
Genetic analysis of novel biomarkers and molecular targets for malignant brain tumors and their clinical application through multicenter collaborative research |
v1:2024/03/05 |
NGS (RNA-seq) |
Illumina (NovaSeq 6000) |
glioma: 124 cases (Japanese) |
Shinji Kohsaka |
Controlled-access (Type I) |
|
DRA017996 |
Investigation of the relationship between the genes involved in dyslipidemia and the pathogenesis of the disease |
v1:2024/02/27 |
NGS (Target Capture) |
Nanopore (MinION) |
Familial hypercholesterolemia: 5 cases 1 Control (Japanese) |
Koh Ono |
Unrestricted-access |
|
JGAS000672 E-GEAD-747 |
Elucidation of proteins associated with the clinical course of refractory neuromuscular diseases using nerve and muscle tissue |
v1:2024/05/17 |
NGS (Visium Spatial Gene Expression) Histological image |
MGI (DNBSEQ-G400RS) |
Thymoma: 7 cases Thymic hyperplasia: 2 cases (Japanese) |
Tatsusada Okuno |
Unrestricted-access Controlled-access (Type I) |
|
DRA017833 E-GEAD-674 |
Relationship between changes in the T-cell receptor repertoire of regulatory T cells before and after pregnancy and pregnancy outcome. |
v1:2024/05/10 |
NGS (Target RNA-seq, TCR-seq) |
Illumina (NovaSeq 6000) |
Healthy pregnancy: 7 subjects Preeclampsia: 3 cases (Japanese) |
Akitoshi Nakashima |
Unrestricted-access |
|
JGAS000684 |
Research to elucidate pathological conditions of skin diseases caused by genetic alterations by multi-omics analysis |
v1:2024/04/03 |
NGS (WGS, Exome, Long-read WGS, Amplicon-seq, RNA-seq) SNP array Methylation array |
MGI (DNBSEQ-T7) Illumina (NovaSeq 6000, MiSeq, Infinium Asian Screening Array, Infinium MethylationEPIC) PacBio (Sequel II) |
8 porokeratosis patients (Japanese) |
Akiharu Kubo |
Controlled-access (Type I) |
|
JGAS000722 |
Molecular Pathological exprolation of Tumor Formation and Functional Differentiation Using Parasellar Skull Base Tumors and Malignant Glioma Tissues |
v1:2024/07/17 |
NGS (scRNA-seq) |
Illumina (NovaSeq 6000) |
craniopharyngioma: 10 cases (Japanese) |
Tatsuma Matsuda |
Controlled-access (Type I) |
|
JGAS000712 |
Analysis of the cancer immune response following radiation therapy for esophageal squamous cell carcinoma and colorectal cancer |
v1:2024/05/31 |
NGS (scRNA-seq, Visium Spatial Gene Expression) Histological image |
Illumina (HiSeq 3000, NovaSeq 6000) |
esophageal squamous cell carcinoma: 7 cases (Japanese) |
Shun-Ichiro Kageyama |
Controlled-access (Type I) |
|
JGAS000723 |
In Vitro Amplification of Human Hematopoietic Tumor Cells and Construction of Mouse Models for Reproduction of Pathological Conditions |
v1:2024/07/25 |
NGS (RNA-seq, scRNA-seq, scBCR-seq) |
Illumina (HiSeq 2000, NextSeq2000) |
multiple myeloma: 21 cases (Japanese) |
Atsushi Iwama |
Controlled-access (Type I) |
|
JGAS000721 |
Establishment and genomic analysis of mixed phenotypic acute leukemia cell lines |
v1:2024/07/25 |
NGS (Exome, RNA-seq) |
Illumina (NextSeq 500) |
mixed phenotype acute leukemiae: 1 case (Japanese) |
Hiroto Ishii |
Controlled-access (Type I) |
|
Japan Prospective Studies for Aging and Dementia (JPSC-AD) study |
v1:2024/11/20 |
SNP-chip |
Illumina (Japanese Screening Array) |
9,479 participants in the JPSC-AD study (Japanese) |
Toshiharu Ninomiya |
Unrestricted-access |
|
|
Genetic background of the development of pelvic organ prolapse |
v1:2024/10/02 |
SNP-chip |
Illumina (Asian Screening Array, Infinium OmniExpress, HumanExome, Infinium OmniExpressExome v1.0, Infinium OmniExpressExome v1.2) |
female participants with a medical history of POP: 771 cases 76,625 control individuals (Japanese) |
Shiro Maeda |
Unrestricted-access |
|
|
JGAS000721 |
Investigation of immune response to cytomegalovirus during pregnancy |
v1:2024/08/14 |
NGS (scRNA-seq) |
Illumina (NovaSeq 6000) |
Pregnant women undergoing early pregnancy screening: 10 individuals (Japanese) |
Mari Ichinose |
Controlled-access (Type I) |
|
JGAS000726 |
Non-clinical research for the development of neuronal cells from human iPS cell derived cerebral cortical organoid |
v1:2024/08/23 |
NGS (scRNA-seq) |
Illumina (NovaSeq 6000) |
Organoids derived from iPS cells of a single healthy individual: 9 samples (Cell-line) |
Jun Takahashi |
Controlled-access (Type I) |
|
JGAS000731 |
Analysis of genes associated with autistic spectrum disorder, schizophrenia, and bipolar disorder |
v1:2024/08/22 |
NGS (Target Capture) |
Illumina (iSeq 100) |
32 children with ASD 8 children with low birth weight 3 children with sub-threshold ASD 36 typically developing children (Japanese) |
Shigeru Yokoyama |
Controlled-access (Type I) |
|
JGAS000740 |
Tumor tissue culture and its characterization in gastrointestinal cancer |
v1:2024/10/16 |
NGS (RNA-seq) |
Illumina (NextSeq 1000) |
Organoids from a colorectal cancer patient: 1 sample (Japanese) Caco-2 cell: 1 sample (Cell-line) |
Nobuo Sasaki |
Controlled-access (Type I) |
# You can search the data in the DDBJ Sequence Read Archive (DRA), the European Sequence Read Archive (ERA), and the Sequence Read Archive (SRA) through the DDBJ Search site.
* The study including processed data by JGA (e.g. alignment results [CRAM], variant call results per sample [gVCF], variant call results per dataset [aggregated VCF] processed in a certain workflow) Learn more
